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Vol. 19 June, 1949 
TREATMENT OF THE HOSPITALIZED 
MENTALLY ILL 
By HARRY c. SoLOMON, M.D. 
o. 3 
T HIS is an exhilarating and exciting period for those of us who are concerned with treat ng the overtly ill mental patient, especially 
those afflicted with major psychoses. The reason for the exhilaration 
arises out of the fact that our efforts are meeting with a degree of success 
which could hardly have been contemplated two decades ago. To those 
of us who have been in the work for two or more decades the change in 
the results obtained with patients in this category is only equalled by the 
change in attitude of the younger physicians entering into the treatment 
of the mentally ill. In our institution, if a patient no matter what his 
diagnosis, does not show distinct improvement in the course of days or a 
few weeks, the physician in charge of the case is disturbed and distressed 
and feels that he has somehow failed to offer the proper treatment. It is 
refreshing to find that the physician's questions are concentrated on the 
treatment. Diagnosis to be sure is important, not as the end of the road 
but rather as an indication of whether the treatment has been the proper 
one for a patient with a certain constellation of symptoms. This change in 
the medical attitude is unquestionably brought about from the fact that 
patients are being helped, that in a large majority of severe acute mental 
illness the expectation is for improvement of a degree sufficient for the 
patient to leave the hospital within a relatively short time and to take up 
his activities in the community as effectively as, or better than, before the 
illness. 
In order to substantiate the statements about the high improvement 
rate I would ask your forbearance while I present to you the results of 
treatment at the Boston Psychopathic Hospital for one year. The year 
chosen is our statistical period of July 1, 1946 to June 30, 1947. This year 
is p icked because it represents pretty accurately the situation as it exists 
today and, a period of 18 months having expired since the end of this 
period, there has been an opportunity to learn something of what hap-
pened to the patients. The statistical findings for the previous year, 
1945-46, are very nearly identical, supporting the significance of these 
results. 
T he Boston Psychopathic Hospital is a small psychiatric clinic main-
tained by the Commonwealth of Massachusetts as part of its state hospital 
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system, with a licensed bed capacity for 117 patients. Patients are ad-
mitted to the institution from any portion of the Commonwealth, but 
chiefly from the Boston metropolitan district. Patients of the old age 
group are not admitted. Otherwise any mentally ill patient requiring 
hospitalization is welcomed. There is usually a greater demand for admis-
sions than can readily be handled, so a waiting list is usually in existence. 
Acute emergencies are of course given precedence and almost always 
accepted if the need is sufficiently great. Patients are admitted from the 
community almost exclusively either on a temporary care paper from a 
practising physician or on a voluntary basis. Another group of . patients 
are transferred from other state hospitals for special diagnostic proced-
ures or special treatment, particularly psychosurgery and treatment of 
central nervous system syphilis. In addition, a considerable number of 
individuals are sent to the hospital for psychiatric survey and study by the 
courts in the district near the hospital. This group, which represents a 
high percentage of admissions, come in for short study and occupy about 
10 percent of the bed capacity of the hospital, the other 90 percent being 
used more specifically for therapeutic purposes. During the year under 
consideration 440 patients were admitted from the community on a doc-
tor's certificate, of whom 36 or 8 percent were committed elsewhere, and 
an additional 118 patients were admitted voluntarily, of whom 1 was 
committed to .another hospital. 
It therefore appears that of the acute problems which came to our 
doors, approximately 90 percent remained for treatment. Of these 558 
patients, 79 percent were returned home from the hospital with an aver-
age stay of 45 days. The remaining 21 percent were sent to larger insti-
tutions of the state hospital system. The reason for the transfer in each 
instance was that it was concluded that further intensive treatment was 
not indicated and that either the patient was for the moment considered 
as heading toward chronicity, for which no immediately applicable therapy 
was advised, or that he needed a convalescent period rather than inten-
sive and definitive treatment. 
It is pleasing to report that of the group who were transferred to 
other institutions, 48 percent improved sufficiently to be returned home 
after some months of care. 
The immediate outcome therefore indicates that ·89 percent of the 
patients admitted to the hospital for treatment during the period under 
consideration improved sufficiently to return to their community activities. 
May I emphasize the 89 per cent figure? Of the remaining 11 percent of 
the to~al patients admitted for treatment, some go on to chronicity and 
some of them improve in the course of several years. Of course the num-
ber who will get well after two or more years of illness is very small. 
However, for the patients who fall into the chronic classification, some 
form of psychosurgery is still available and, as will be indicated shortly, 
with the expectation of some good results. It may be added at this point 
that there will certainly be some relapses among the 89 percent who have 
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done well. Among the cases that relapse, some will have brief illnesses 
with recovery, some occasional severe illnesses, and some others will fall 
into the chronic category, and again fo r them psychosurgery will be avail-
able to benefit a fair percentage. 
It is on the basis of these results with the acutely ill patients that I 
believe enthusiasm for modern therapy can be justified. 
It is now in order to attempt to describe what is meant by the present 
day psychiatric therapy. All therapy must of course stem from careful 
diagnostic study of the individual to be treated . Such study includes a 
good general physical and neurological examination of the patient, with 
all the aids that general medicine has at its command which, in certain 
cases, would include rather special neurological studies such as electro-
encephalography and airencephalography. It includes in addition a care-
ful psychiatric analysis of the case, with the assistance of the available 
batteries of psychological tests, and interviews aided by such drugs as 
sodium amytal, sodium pentathol and pervitin. 
From the therapeutic standpoint psychiatry has at its service today a 
number of procedures and aids which can be briefly summarized in two 
groups, the first of which I will call the definitive psychiatric therapies 
and the second the general and socializing therapies. 
Definitive Psychiatf'ic Thef'apies 
Psychotherapy 
· (a) Individual 
(b) Group 
Convulsive Shock 
Insulin Shock 
Lobotomy 
Penicillin and Fever 
Genef'al and Socializing The,.apies 
Psychiatric Nursing 
Occupational Therapy 
Psychiatric Social Service 
Recreation 
Physio and Hydrotherapy 
General Environment 
These are the therapeutic processes that are responsible for the bene-
ficial results I have mentioned. Until some 15 years ago our treatment 
procedur-es were limited to individual psychotherapy and the general and 
socializing therapies. In recent years the addition of the other so-called 
somati' therapies has aided a great deal toward a favorable prognosis. 
At the same time psychotherapy has become more effective and our gen-
eral therapeutic processes have been improved. It is not possible to give 
a cleat depiction of what each of our treatment procedures has added to 
the general over-all recovery and improvement rate of patients because 
each has unquestionably added its share, but some general ideas of ~alues 
of some of the procedures may be considered. 
Convulsive shock therapy has been a very effective therapeutic tool 
for a great many patients. Approximately 90 percent of the patients in 
the manic-depressive group treated by convulsive therapy are returned to 
a good mental status in a matter of days or weeks. The course of an 
attack is telescoped. Many patients in the schizophrenic groups are also 
impro·red sufficiently to lead comfortable community lives in relatively 
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short period. Of 157 patients at the Boston Psychopathic Hospital whose 
only specific therapy was electric convulsive, 83 percent recovered suffici-
ently to return to their homes. This included patients whose symptom 
constellation placed them in several diagnostic groups. 
At the Westchester Division of the New York Hospital Drs. Hamil-
ton and Wall made a very careful study of 100 consecutive female admis-
sions with a diagrosis of schizophrenia who were treated by short courses 
of convulsive shock, and reported that 67 percent made a reasonably 
prompt recovery. This was approximately twice as great a recovery rate 
as had been obtained in a previous period at the same hospital with essen-
tially similar treatment aside from the convulsiv~ therapy. 
This type of therapy also has an amazing therapeutic value in cases 
of the involutional psychoses in which group the psychoses may be short-
ened by months or years, in contrast to cases that do not receive this type 
of treatment. 
Probably the most spectacular effect of this type of treatment is 
obtained in cases of acute confusion and excitement. Such cases which in 
a few instances without this treatment go on to death, the so-called Bell's 
Mania, can be brought to a state of reasonable social behavior in a matter 
of days, and the jeopardy of death in the excitement is eliminated. The 
alleviation of excitements of almost all varieties, even when due to 
organic disease of the brain, can be usually accomplished very quickly. 
This obviates many grave dangers to the welfare of the patient and at the 
same time produces a condition in the wards that allows for better treat-
ment of all the patients. 
_Perhaps a brief account from a nurse's report of the care of one 
patient will illustrate these latter points. 
A 23-year-old woman was admitted to the hospital nine days after 
delivery of a daughter. She was tense, apprehensive and irritable. She 
was disoriented and misidentified people. She was in a state of great 
turmoil, was impulsive and was responding to auditory and visual halluci-
nations. She believed that someone had taken her baby from her and that 
her husband was unfaithful to her. She responded in an aggressive man-
ner to the voice of a doctor by whom she had previously been treated. At 
times she was combative, assaultive and would explain her violence by 
saying "Dr. C. told me to do it." She would not keep any clothes on and 
any attempt made by the nurses to ke'!p her clothed was met by aggressive 
action on her part. 
·on admission she showed signs of sepsis; her temperature reachel 
102°; she became jaundiced, her breasts were engorged, she was 
dehydrated and, because of her restiveness, it was difficult to m3.intain an 
adequate fluid level. 
After three electric shock treatments a remarkable change in her 
mental state became apparent. She became co-operative, well oriented 
and free of hallucinosis. Her general physical condition improved 
TREATMENT OF THE Ho PITALIZED MENTALLY ILL 93 
markedly; she ate normally. In less than three weeks she was relatively 
well and able to go home for a week-end visit . The nursing problem, 
which for the first three days before shock was administered was 
extremely dificult and far from adequate in its results, became simple and 
effective. 
Convulsive shock treatment offers an opportunity for the alleviation 
of distressing symptoms, following which a better relationship may be 
established between patient and staff than can be obtained without this 
means. Regulation of a patient's sleep is part of the effects as is the lack 
of feeding difficulties. With proper sleep and nourishment, with reason-
ably good social contacts, treatment procedures may be carried out which 
under other circumstances would be quite impossible. Undoubtedly this 
whole group of circumstances affords a better opportunity for the recov-
ery potentials of the individual to make themselves felt . 
Insulin shock therapy in our hands has been reserved largely for 
those patients who have failed to respond to general care and convulsive 
therapy and for whom it is believed that psychotherapy alone is not ade-
quate. In the case of certain schizophrenics insulin therapy is introduced 
early in the treatment program without the use of convulsive shock, but 
by and large in our cases convulsive therapy is first tried and if found 
ineffective insulin is given. 
In the year under consideration 51 cases were given insulin coma 
therapy ; 37, o r 73 percent, improved sufficiently to be discharged home. 
When it is recalled that most of these patients were unsuccessfully treated 
before they were given isulin , the value of this treatment is apparent. 
There are relatively few well controlled series of patients treated with 
insulin in comparison with untreated cases. However, where it has been 
done, notably the Brooklyn State Hospital g roup, the evidence was strong 
on the point of the value of this type of treatment. 
During the course of insulin coma t reatment one is impressed by 
several observations. The patients in general thrive physically, they put 
on weight, they look well and they sleep well. Perhaps even more im-
portant, most of the patients become friendly and readily develop a warm 
relationship with the staff. Personall y, I am continuously amazed that 
most patients receiving insulin coma treatment put up no resistance 
thereto but,on the contrary, seem to take pride in being a member of the 
treatment g roup. They feel , apparently, that they are especially distin-
guished thereby. All of this is important and helpful to the patient and 
probably in itself plays a role in the road toward improvement. 
Psychotherapy in the general care of patients is of great importance. 
Psychotherapy in the course of the years has found itself in relation to the 
treatment of the psychoses. It is not the intent of this discourse to discuss 
the details of techniques. Suffice it to say that as our understanding of 
psychological dynamics has become greater, more definitive psychological 
treatment is available. In most cases the use of individual and group 
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psychotherapy is part of the total treatment program, and in a great many 
cases psychotherapy and general care represent the major if not the total 
program. 
The decision as to what form of treatment to use and when to app!y 
various methods is a matter that needs fine judgment. As in all treatment 
procedures, discrimination and judgment on the part of the physician 
directing the program is the first requisite. That judgment is not always 
perfect follows from the fact that medicine is still an art. The results of 
treatment of psychotic patients will vary according to the wisdom and 
ability of the physician as well as to the intrinsic capacity of the patient 
for recovery and the value of the therapeutic methods. Improperly chosen 
methods or the application of a method at the wrong period may be 
harmful rather than beneficial, and continuous study of our techniques 
is necessary. It will be long before we are able to offer a systematic 
formula which he who reads may utilize successfully. 
It is my firm belief that the general and socializing therapies of the 
hospital should play a very heavy role in the total treatment program, and 
I have no doubt that the effectiveness of the treatments mentioned is 
dependent upon the skill and excellence of the 24-hour-a-day care of the 
patients. The conditions under which any individual lives greatly influ-
ence his reactions and behavior. If war experiences taught us anything, 
they taught us that emotional stress could cause grave damage to humans. 
They taught us that general morale was essential for adequate behavior. 
The same is true of the mentally ill patient in a hospital. If conditions 
are adverse it is hardly to be expected that the patient will flourish and 
improve. Catatonic syndrome is in many instances merely an expression 
of intense fear on the part of the patient who feels himself separated 
from human relationships and thus tries to hide within his own skin. If 
such an individual is met with aggressive behavior on the part of those 
who are looking after him, if he feels coldness in the emotional atmos-
phere, if his fear is increased by harsh words and restrictive and suppres-
sive measures, he either retreats further into himself or becomes 
assaultive. Skillful treatment in the early period of hospitalization by the 
nursing staff is probably more important than the doctors' skills. It is 
our experience at the present time that the so-called catatonic retreat 
rarely lasts more than 24 to 48 hours; kindly understanding, sympathy 
and attention on the part of the nursing staff almost invariably lead to 
overcoming mutism anq refusal of food. With good nursing and with 
the proper utilization of the specific psychiatric therapies, the acute wards 
of the hospital become not unpleasant places in which to be. Where 
aggressive and assaultive behavjor is at a minimum, where the ward is 
quiet and the patients not too disturbing to others, a better chance for 
recovery exists than where tempestuous and distressing behavior pre-
dominate. In the ward where the patients are well behaved attention can 
be given to esthetics and this I believe has a very beneficent effect. The 
use of pleasing colors on the wards, an occasional picture, attractive bed-
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spreads, drapes on the windows, comfortable chairs and a spirit of friend-
liness in the ward are extremely important details in the care of the 
patients. 
The hospital allows no form of restraint except post-operatively 
when a patient's hands may of necessity be restrained to keep him from 
removing bandages and infecting a wound. No "legitimatized" restraint 
such as packs or prolonged baths are used nor is chemical restraint, in 
the form of sedative drugs to quiet a patient, permitted. 
With the elimination of restrictive methods, the need of seclusion 
drops to a minimum. To be sure, occasionally a patient who becomes a 
little disturbing to others may have to be temporarily isolated, but this is 
rarely for more than an hour or two at a time. 
The nurses and attendants in this circumstance become important 
members of the therapeutic team. Upon their shoulders rests the responsi-
bility of seeing that the patient has the proper environment in which to 
live a somewhat reasonable existence. The nurses and attendants are 
challenged to use no force, to win the confidence of the patients through 
understanding their behavior and the factors that motivate them. This 
requires not only extreme skill but much understanding forbearance. · 
Perhaps a picture of the nursing problem can be best presented by a 
quotation from the nurses' notes concerning the patient briefly mentioned 
above. 
Feeding problem: On admission Phyllis had many _paranoid tenden-
cies, so therefore she refused food, accusing us of putting something in 
it. With much patient persuasion she would drink a glass of milk, egg-
nog or eat some food . However, she was very unpredictable and just 
when we had become quite confident in her she would throw the milk at 
us or pour it on the floor and play with it. 
"Under the influence of sodium amytal she was fed, bathed, clothed, 
mouth care was given and blood was taken for examination. 
"Elimination: She defecated and urinated on the floor several times 
a day. More frequent toile~ing helped this somewhat. She was changed 
from one seclusion room to another to keep her as clean as possible. 
Probably due to her overactivity, there was still more lochial discharge. 
She masturbated at times and when spoken to would say, 'I shouldn't do 
that, should I?' 
"Fersonal hygiene: Her lips were cracked and dry due to her over-
activity, refusal of fluids and elevated .temperature. Her t~eth became 
coated and her tongue parched and dry. Ointments were applied to her 
lips and, under sodium amytal, mouth care given. This didn't seem to 
have too much effect on her broken, bleeding mucous membranes. 
"As she was denudative it was difficult to attain bodily cleanliness as 
she would lie on the bare floor, ignoring the mattress, refusing any type 
of clothing, even slippers on her feet . She also played in feces , covering 
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the walls with it. When placed in the bathtub, Phyllis seemed to have no 
regard for her surroundings and splashed freely, succeeding in getting 
the floor and screens all wet. 
"Her body was badly bruised, especially her legs, arm~ and the back 
of her neck. Her bed had been removed from the room to prevent any 
further injury to herself SQ that only the mattress and blanket remained. 
as she destroyed sheets, etc., if given to her. 
"Her door was locked to prevent disturbing the other patients. She 
was unpredictable and became assaultive to nurses who would try to feed 
her or care for her in any way. At times she would hug another nurse 
and express homosexual desires. Being denudative was also an important 
reason for placing her in seclusion. 
"As far as relationship with patients and personnel was concerned. 
Phyllis had her own companions with her visual and auditory hallucina-
tions. She would stand in a catatonic-like position, look at the light, see-
ing the 'twinkle' in Mac's left eye also saw this in other people's eyes. 
She would wink and laugh inappropriately in response to many things 
said to her. 
· "There was a definite problem in keeping the breast binder on, pre-
scribed because of engorged breasts, although she said they didn't pain 
her. Pins, of course, couldn't be used, therefore wide tape was substi-
tuted. She would only keep this on for a _short period of time. 
" Now that most of these previous problems have subsided, the pres-
ent problem is that of keeping her active." 
Now that Phyllis is well she is most grateful to the nurses whom she 
so badly tormented, and they are more than pleased with the effectiveness 
of their contribution to her recovery. The last sentence of the notes above 
CjUOted states that the present problem is to keep her active and here is 
where the matter of occupational therapy and recreational facilities come 
m. It is with the acutely ill patient that occupation and recreation are 
most needed. I fear that too fre<:juently these procedures are afforded 
patients who are already well enough to take advantage of them. Our 
efforts are now directed toward giving the maximum in occupation and 
recreation to the patients who are too ill and too poorly socialized to go 
to an occupational therapy room. It is in the acute ward that the occu-
pational therapist and the recreationalist can perhaps offer the greatest 
benefit. As the patient improves in his general behavior and socializing 
possibilities he can gain more freedom of action and have perhaps a 
greater scope for his abilities, but it is in the early and acute stage of his 
illness that special study by the occupational therapist probably pays the 
greatest dividends. 
As one learns more and more of the internal mechanisms of the 
patient one learns more concerning fear and apprehension and anxiety on 
the one hand and resentment, sense of frustration and objection to being 
bos ed. The elimination of factors leading to such viewpoints is an 
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essential feature of general psychiatric treatment. As far as is consistent 
with the welfare of others, the patients are allowed to express themselves. 
The patients on our more convalescent wards have a self-governing 
committee composed of men and women patients who make their own 
rules and regulations, assign tasks and police the wards. If 9 hours are 
given over to sleep, there remain 15 hours to be occupied in some fashion 
by the patient. If left to themselves they soon slump into a state of inertia 
or destructive activity or retreat into ruminating and hallucinating 
phantasies. 
It is rarely possible for a hospital to have a staff sufficiently large to 
give the necessary individual and group attention to patients. Therefore 
assistance must be obtained from various sources. The development of 
initiative and responsibility on the part of the patient is important. Stu-
dents working and learning at the hospital add a good deal to the interest 
and color ·of the daily life of the patient. Volunteers of many varieties 
can add greatly to the interest of a patient's day. Many, if not most 
mentally ill patients have great difficulty in inter-personal relations. 
Many are shy, most feel out of touch with other persons. The socializing 
efforts which can be applied become valuable therapies. In our hospital, 
in addition to the attention given patients by students of several 
disciplines such as psychologists, sociologists, psychiatric social workers, 
nurses and clerics, much satisfactory work is done by volunteers. 
Perhaps a good viewpoint to hold is that if a patient is unfortunate 
enough to be so ill as to need treatment in a mental hospital, his stay 
should be utilized to give him new outlets, new interests and perhaps new 
skills. He should have some things in his repertory of capacities over and 
above what he had when he entered the hospital. A dancing class has 
been found to afford the patient great interest; similarly cooking and 
candy-making, hat-making and dress-making offer the development of 
skills that have value to the patient on leaving the hospital. 
During the year under consideration 166 patients were subjected to 
the lobotomy operation. The patients who received this type of treatment 
were selected on the basis of a long period of mental illness with the con-
clusion having been reached that the probability of recovery through any 
other form of treatment was extremely small. Of this group of 166 
patients, 75 ( 45% ) returned to their homes with some degree of improve-
ment. The majority of these patients were in the chronic stage of schizo-
phrenic psychosis, namely 123 out of the 166. The results in these patients 
were approximately the same from a percentage standpoint as for the 
total group. 
The greater majority of the patients who were subjected to the oper-
ative procedure were sent to the Boston Psychopathic Hospital from the 
larger hospitals of the state hospital system. The group was made up of 
patients many of whom had been in hospital for a great number of years 
and who were extremely disturbed distressed and distraught. A smaller 
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portion of the patients had been ill or hospitalized a much shorter period 
of time, in the neighborhood of two years, and had very intensive treat-
ment in the present mode but had failed to respond satisfactorily. There 
were 47 such patients operated upon of whom 3 7 or 97 percent were able 
to return to community living. This is in considerable contrast to the 
group that have been sent to us after a long hospital stay, of whom only 
26 or 24 percent of 105 patients were sufficiently improved to allow them 
to go home. This result is consistent with the experience of others as 
well as ourselves, namely that a greater degree of success from psycho-
surgery is to be expected in patients who have not been ill too long. 
I would emphasize that of the type of patients who seek service in 
an acute hospital installation such as ours and who come to psychosurgery 
because of failure of our other forms of treatment, a distinct improve-
ment can be expected in well over 50 percent. It is our procedure.in many 
cases to give the patient the treatment which we are able to offer at the 
time of admission and, if improvement does not occur, the patient, unless 
he has been ill for a considerable period of time before admission, is sent 
to a larger hospital with chronic facilities with the idea that if, in the 
course of a year or 18 months, improvement has not resulted, he will be 
returned to us for psychosurgery. 
Let us review then what our experience indicates as the fate of the 
type of patient who enters our hospital as a more or less acute mentally 
ill individual. On the basis of treatment which we have availaible and 
which we have already discussed, it is seen that nearly 80 percent will be 
returned home in an improved state ditectly from our institution, that 
some 20 percent will be sent to other mental hospitals for more prolonged 
care and that of these approximately one-half will make a sufficient 
improvement to return to their homes within 18 months. This accounts 
for almost 90 percent of the patients. Of the remaining 10 or 11 percent 
who have failed to recover and may be considered as chronically ill, a 
considerable number will be good subjects for psychosurgical interven-
tion, and of those who receive such treatment more than 50 percent will 
be benefitted sufficiently to be out of the hospital. One arrives at the 
astounding if not phantastic figure of well over 90 percent of the patients 
entering a hospital such as ours being returned to the community. 
I have carefully avoided the use of the word "cured" or "recovered," 
not because I think that the term is not applicable but because there is 
such a strong sentiment or prejudice in the minds of most people, psychia-
trists, psychologists and nurses, as well as the layman, to talking about 
recovery of the mentally ill. The question always is asked, "But do the 
patients remain well? Don"t they relapse?" Indeed this is a proper ques-
tion as it is in the case of cancer or heart disease or perhaps pneumonia. 
Some of the patients about whom I have given these statistics relapse 
or have another attack of mental illness. Indeed this is characteristic of 
patients who have a manic-depressive psychosis and it is true for a con-
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siderable number who are diagnosed as having schizophrenia. Unfortu-
nately I am not able at this moment to furnish accurate statistics about 
recurrence of mental illness in the patients of our group. Such a study is 
being conducted but is not far enough advanced to be discussed. The 
number who break down within a one, two or three year period, however, 
is not great. Those who do have a recurrence or a new attack are usually 
treatable again and the results of the treatment of the new attack are on 
the whole rather similar to what has been described above. A certain 
percentage do fail to recover from a second, third or subsequent attack of 
mental illness and become chronic. These patients again form a group 
for whom psychosurgery offers great advantage. It is from this group 
that perhaps the best results of operative intervention are to be expected. 
I would belabor the point that too much pessimism exists about recur-
rence of mental disorders in individuals who have once been afflicted and 
would emphasize the point that there is not as great a danger as is often 
believed, but I would emphasize more especially that recurrence may be 
of very short duration and the outcome excellent. I would point out that 
the period of disability in many of the patients in our group is relativ~ly 
short- ten, twenty, thirty, forty or fifty days. 
Another tendency in thinking of mental disorder which has had a 
deleterious, almost paralyzing effect, is to be overly concerned as to 
whether recovery occurs without any defect. In hardly any other field of 
medicine does one expect complete restoration. 
It has been stated in the course of these remarks that general care 
and psychotherapy are utilized and relied upon either as a total or cer-
tainly as an associated treatment procedure in most cases. Treatment does 
not necessarily cease when the patient leaves the hospital--on the con-
trary it is after returning home that most intensive work is often neces-
sary. Many of our patients continue treatment for weeks or months as 
out-patients. Prior to as well as after the return home it is often important 
that much work be accomplished with the families of patients, and in this 
sphere of endeavor the psychiatric social workers have a big stake. 
As we scrutinize the results of our experience in the treatment of 
patients with acute mental illness we come to the conclusion that the 
opening statement of these remarks is correct, that it is indeed a period in 
which we have reason for hope and a considerable amount of satisfaction. 
There are many, many things still to be accomplished. However, with the 
methodology at hand, it would appear that a concentrated therapeutic 
attack upon the early stages of a patient's illness brings worthwhile 
results. General Eisenhower in his book "Crusade in Europe" stressed 
that in the campaign it would have been more costly to set up a perfect 
line of defense and sit tight than to continue a vigorous offensive. Simi-
larly an intensified offense toward early treatment of the mentally ill 
would seem to be infinitely more effective than preparations for pro-
longed care of patients who have not been given the utmost at the period 
of onset of the illness. 
ADVANCES IN GASTRIC SURGERY 
By RAYMOND W. McNEALY, M.D. 
T HE advances in gastric surgery have been of an evolutionary type. On the whole, they have developed along lines which have had their 
foundations in mechanical rearrangements of the viscera with a view of 
eliminating the pathology, at the same time preserving a gastro-intestinal 
continuity. 
Gastric resections were performed successfully as early as 1879. The 
first resection was done for carcinoma involving the pyloric end of the 
stomach. It is very interesting that gastric resections were done before 
the technique of gastro-enterostomy was developed. The first gastro-
enterostomy was done by WoHler in 1881. It was performed for an 
unresectable carcinoma of the pyloric end of the stomach. The first 
gastro-enterostomy for a benign ulcer of the duodenum with pyloric 
stenosis was done in 1884. 
The operation of gastro-enterostomy was popularized in the United 
States following a visit in 1902 of Sir Berkley Moynihan. This operation 
gamed great favor in the treatment of peptic ulcer and its complications. 
It was revealed by careful follow-up of these gastro-enterostomy patients 
that stomal and jejunal ulcers were serious complications in more than 25 
per cent. About 1927 Finsterer and other continental European surgeons 
stressed the value of partial gastric resection for peptic ulcers that were 
unsuited to medical management. 
Even partial gastrectomy left much to be desired, for some of these 
patients developed stomal and jejunal ulcers. 
Vagotomy has been suggested as a means of lowering the acid-
pepsin factor which is generally conceded to be the perpetuating influ-
ence of ulcers in the upper gastro-intestinal tract. The thoracic approach 
to the vagus nerves afforded the most reliable method for exposure and 
complete division of these structures. This exposure, however, had the 
disadvantage of allowing no exploration of the stomach and duodenum 
or of the other viscera in the abdominal cavity. The abdominal approach 
had the advantage of permitting exposure and examination of the viscera 
but the dissection and complete division of both vagi and all their 
branches were far more difficult. There was a further complication that 
developed in those whose nerves were severed. They developed motor 
deficiencies which were followed by poor emptying and gastric dilatation. 
Gastro-enterostomy or partial resection seemed necessary as a supple-
mentary measure to vagotomy. 
There have been several very dependable studies made on these 
patients with vagotomy. The final evaluation of this procedure cannot 
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be made at this time. The operations have not been of one type in enough 
cases to permit one to draw conclusions as to the merit of this type of 
surgery. 
We have had very few successes in surgery which were the result of 
mechanical interventions in physiological activities of the body. Our 
resection of the major portion of hypersecreting goiters has been the most 
outstanding. Resections of other hypersecreting endocrines have also 
been successful but they are not so numerous as to give great encourage-
ment to less direct invasions of the field of unbalanced physiology. 
Our advances in gastric surgery in 70 years leaves much to be 
desired. There is much to be done. 
NEW DRUG ON PRESCRIPTION ONLY 
Ottawa, Feb. 28.- Hon. Paul Martin , Minister of National Health and Wel-
fare, announced to day that it had been found necessary to add to the list of 
drugs to be sold only on prescription, Tetraethylthiuram disulphide, commonly 
known as Antabuse or Abstinyl. 
He pointed out that this drug, which is very potent, will be available on the 
Canadian market almost at once, and that, in view of its effects, had to be 
restricted as to sale. 
A STIJDY OF THE ADRENERGIC BLOCKING 
AGENT, DIBENAMINE 
- (N,N-dibenzyl-beta-chloroethylamine) 
By MARloN G. MARsHALL 
History 
T IllS chemical is a member of a series of tertiary amine~ whjch have recently been found to possess considerable power and specificity as 
adrenergic blocking agents, both in animals and in man (9, 10, 13, 23). 
First of the series to be discovered, and described by 0. Eisleb in 1930, 
was Dibenamine. The original synthesis of this drug in North America . 
was by Dr. W. Gump of Givaudan-Delawanna, Inc. of New York. This 
chemist has subsequently prepared a number of the congeners and related 
compounds of Dibenamme. 
The pharmacology of Dibenamine was first studied by Nickerson 
and Goodman of the Unjversity of Utah School of Medicine. They 
reported at a meeting of the American Federation for Clinical Research 
in March, 1946 (15), and later in the literature (14), a large number of 
experiments on animals and a more limited number on man. The detajled 
pharmacology with regard to man was studied by Hecht and Anderson in 
the Department of Medicine of the University of Utah. Since that time 
Givaudan-Delawanna has supplied the drug to a number of other labor-
atory and clillical workers for investigational use. The distribution for 
clillical studies is now in the hands of Smith, K;line, and French labora-
tories, Philadelphia. 
Chemistry 
The chemicals of the series of which Dibenamme is at present of 
greatest interest, and thus here considered as the prototype, are beta-
chloroethylamines. At least one chlorine and one benzyl group was found 
to be necessary for activity of the series (7). The series is chemically 
related to the nitrogen mustards (bis- and tris-chloroethylarnines). 
Although Dibenamine does not have the second beta-chloroethyl 
grouping of the nitrogen mustards, it exhibits many of their characteristic 
chemical reactions. This fact affords a clue to the possible type of chem-
ical union between Dibenamine and the adrenergic receptor substance. 
Nickerson believes that such a chemical union does take place (16) -and is 
responsible for the action of the drug; at present further investigations 
along this line are being carried out ( 13). Since it is known that nitrogen 
mustards owe their pharmacological activity to an intra-molecular ring 
formation with liberation of chlorine, a similar mode of action has been 
proposed for Dibenamine (7). . 
It is believed by Nickerson (13) that Dibenamine m aqueous solu-
tion may undergo intramolecular rearrangement to form a cyclic ethyleni-
monium cation. Dibenamine presumably exerts its pharmacodynamic 
effects through this intermediate product, for ethylenimoruum cations are 
known to have great chemical activity. 
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In aqueous solutions at normal body pH, Dibenamine after cyclizing 
reacts with water to form the alcohol, N - N - dibenzyl ethanolamine 
which is inactive as an adrenergic blocking agent. 
Physical Properties and Administration 
Most of the investigators of Dibenamine have ma~e use of the hydro-
chloride salt, because it is more easily handled than the free base which is 
an oily liquid. There is, however, no real difference in the activity of the 
compound or any of its salts with organic or inorganic acids (13). 
The hydrochloride is a white crystalline substance almost insoluble 
in water near neutrality but soluble in aqueous acid solution of 957o 
.ethanol, and in propylene glycol. The present distributors of the drug 
supp,ly ampules for intravenous administration as a 57o solution in 
alcohol-propylene glycol, acidified for stability . . 
Dibenamine produces its systemic effects when given orally, intra-
venously, subcutaneously, or intraperitoneally. However, it can be 
administered in man only by the first two routes. 
Pharmacodynamics 
The systemic effects of Dibenamine, when administered in the proper 
manner and in physiological dosage, an: of a single type: blockage of all 
excitatory adrenergic functions . Not only are epinephrine and circulating 
sympathin rendered ineffective but also, by a slightly larger dosage of the 
drug, direct or reflex stimulation of the sympathetic nerves. 
Dibenamine does not affect inhibitory adrenergic functions, in fact it 
often unmasks these, by removal of the excitatory elements of res.ponse, 
to produce rather remarkable effects. 
I. Actions on the Cardiovascular System 
1. (a) Normal Laboratory Animals 
Dibenamine administered slowly in full blocking doses pro-
duces no significant changes in blood pressure, basal hea.rt rate, 
cardiac output, or electrocardiogram (13) . 
(b) Resting, Non-hypertensive Human Subjects 
The effects of Dibenamine are similar to those in laboratory 
animals. However, when these human subjects rise from a supine 
position there occurs a marked orthostatic hypotension, which is 
maximal in 6 hours and lasts 1 to 2 days or longer (7). This 
temporary hypotension is apparently due to the pooling of venous 
blood in the extremities because Dibenamine abolishes reflex 
postural sympathetic vasoconstriction. The recovery then is seem-
ingly due to the adjustment of vascular muscle to maintain blood 
pressure in the absence of sympathetic nerve impulses as after 
sympathectomy. 
2. Adrenolytic Action 
(a) In Animals 
In epinephrine-treated animals, Dibenamine not only blocks, 
but actually reverses the pressor response. This response is true 
for all doses of epinephrine investigated ( o.1 microgram to 10 
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mg.jkg.) (14). Only the excitatory (vasa-constricting) act1v1ty 
of epinephrine is blocked and the fall in blood pressure is there-
fore due to the unrestrained effect of the concurrent inhibitory 
( vasodilating) activity of epinephrine. This is illustrated by the 
fact that t]le fall in blood pressure with a massive dose of epine-
phrine lasts only until the concentration of circulating epinephrine 
has fallen below the value necessary to produce vasodilation. 
Another proof of this strange fact is that in the rabbit which, 
unlike most laboratory animals, does not have an adrenergic vasa-
dilating system, Dibenamine prevents an epinephrine-induced 
pressor effect but does not reverse it (13). 
The chronotropic and positive inotropic effects of epinephrine 
on the heart are not, in animals, changed by Dibenamine (1 , 13) , 
and sinus rate, stroke volume, and cardiac output are increased as 
usual. Nickerson believes the explanation for this seeming con-
tradiction to the adrenolytic action of Dibenamine to be the exist-
ence of a basic difference in the effect of epinephrine on the sino-
auricular node and on the force of myocardial contraction from 
its effect on vascular smooth muscle. 
The ability of epinephrine to evoke ventricular arrythmias in 
animals under cyclopropane anesthesia is prevented almost abso-
lutely by Dibenamine, although in Nickerson's study (13, 14) by 
a larger dose than is required to reverse the pressor effect of the 
same dose of epinephrine. NiFkerson reports an experiment with 
dogs in which the controls, unprotected by Dibenamine, devel-
oped ventricular extrasystoles . multiple focus tachycardia, andj or 
ventricular fibrillation. Those receiving Dibenarnine 30 minutes 
previously developed only sinus tachycardia with the very occa-
sional extrasystole. In other experiments up to 500 times the 10 
microgram dose of epinephrine was administered after Dibena-
rnine injection without the development of any serious ventricular 
arrhythmias. Since sinus tachycardia always appears in spite of 
Dibenamine, this is probal!lly produced by a different action of 
epinephrine than that which provokes arrhythmia. 
Garb and Chenoweth (3) report -slightly different findings 
from those reported by Nickerson. They note that ventricular 
fibrillation can be caused by the interaction of any hydrocarbon 
and any sympathomimetic amine and that Dibenamine is as effec-
tive against this arrhythmia as that caused by the combination of 
cyclopropane and epinephrine. Their experiments also demon-
strated the fact that Dibenamine is an efficient protecting agent 
against ventricular fibrillation even in very small doses (3 
mgmjkgm) which do not reverse the hemodynamic effects of 
epinephrine. This is seemingly contrary to the opinion of Moe 
et al. (12) who state Dibenamine "prevents ventricular rhythms 
because it prevents the pressor response to epinephrine." However. 
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Garb and Chenoweth found that, although ventricular fibrillation 
was prevented by these very small doses of Dibenamine, hetero-
topic rhythms developed as frequently as in experiments without 
Dibenamine. They believe, therefore, that the antifibrillatory 
effectiveness of Dibenamine in doses too small to reverse the 
pressor effects of epinephrine is related to the quinidine-like 
action of Dibenamine described by Acheson ( 1) in experiments 
on a heart-lung preparation of a dog and an isolated rabbit 
auricle. 
(b) In Man 
In epinephrine-treated human subjects, Hecht et al. (7) found 
that Dibenamine did not reverse the pressor effect, except in one 
of ten subjects, this being an individual with arteriosclerotic heart 
disease. Dibenamine, however, caused the systolic blood pressure 
to rise only slightly while the diastolic fell strikingly. The increase 
in pulse pressure was thus rather marked. 
Nickerson (13) states that in some experiments in man. 
Dibenamine not only greatly reduced pressor response to epine-
phrine, but actually reversed it, as is seen regularly in animals. 
The chronotropic and positive inotropic effects of epinephrine 
on the heart in man are not affected by Dibenamine, exactly as is 
the case in laboratory animals. Sinus tachycardia, increased ·cardiac 
output, greater peripheral blood flow, and T-wave changes in the 
electrocardiagram which epinephrine ordinarily produces are still 
seen after Dibenamine administration. However, epinephrine-
induced ectopic ventricular beats are decreased markedly. 
Ominous types of ventricular rhythms occurring in surgical 
patients under cyclopropane anesthesia can be reduced in num-
ber, shortened in duration, or even abolished by the use of Diben-
amine as shown by the experience of the Department of Anes-
thesia of the University of Utah ( 13) . As was noted in animals 
by Nickerson, larger doses of Dibenamine are needed than those 
which block or reverse the excitatory responses to stimulation of 
the adrenergic system. 
3. Sympatholytic A ction 
(b) In Animals 
The response to both direct and reflex sympathetic nerve 
stimulation after Dibenamine administration has been studied in 
animals .in a variety of expetiments. Nickerson ( 13, 14) demon-
strated the reversal by this drug of the vasopressor response to 
electrical stimulation of splanchnic nerves. This is seen both in 
the intact animal and after bilateral adrenalectomy. This latter 
operation ensures the demonstration of the effect of D ibenamine 
on the splanchic nerves alone since it makes impossible the release 
of adrenalin or any sympathin into the systemic circulation. Some-
what larger doses of the drug than those which blockade epine-
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phrine and circulating sympathin are required to be effective 
against adrenergic nerve stimulation. 
In addition to blocking of this regional sympathetic nerve dis-
charge, Dibenamine has been shown {13, 14) to reverse the 
pressor response to generalized sympatho-adrenal discharge. 
Atropinized cats were injected with a large dose of carbaminoyl-
choline. Atropine prevents the vasodilator and cardiodecelerator 
effect of this choline ester leaving intact one element only of its 
nicotinic properties: the ability to stimulate the sympathetic 
ganglia and the adrenal medulla. Dibenamine is able to reverse 
both components of the rise in blood pressure; and, after bilateral 
adrenalectomy, to reverse the single rise due to sympathetic 
ganglionic discharge alone. 
Reflexly-elicited generalized adrenergic discharge is also 
blocked by Dibenamine. Nickerson {13, 14) reported experiments 
on cats subjected to periods of anoxia after Dibenamine. The 
expected rise in blood pressure is converted by this chemical to 
a fall. 
(b) In Man 
The response to reflexly-elicited sympathetic nerve stimula-
tion in human subjects after Dibenamine administration was 
reported by Hecht {7) . Studies were made with the cold pressor, 
breath-holding and Flack tests. In each of these Dibenamine 
either markedly diminished, abolished, or reversed the expected 
vasopressor response. The orthostatic hypotension developing 
after Dibenamne, referred to above, also illustrates the blocking 
of reflexly-elicited sympathetic nerve stimulation so that postural 
vasoconstriction does not occur. 
4. Action on Sympathomimetic Amines Other Than Epinephrine 
(a) In Animals 
The effect of previous Dibenamine administration on the 
responses to some 25 sympathomimetic amines has been tested. 
With all of these the customary pressor response is markely de-
creased although it is reversed in only certain cases {13). Com-
plete blocking and reversal is seen with amines having ~e 
3-4-catechol nucleus and an aliphatic substitution on either the 
nitrogen or the beta carbon. Reversal is more difficult with 
amines which have a single hydroxyl group on the aromatic 
nucleus. Special conditions are required to reverse straight chain 
amines, those with an unsubstantial aromatic ring, and those with 
an aliphatic substitution on either the nitrogen or the beta carbon. 
To give specific instances, it has been found that Dibenamine 
in its usual dosage does not completely block the effects of tua-
mine or of benzedrine. This will mean, in a practical way, that 
these drugs could be used to elevate Dibenamine-depressed blood 
pressures in cases where this should prove necessary. 
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Nor-epinephrine, according to several investigators as, for 
instance, Goldenberg et al ( 4) , is actually Sympathin E, one of 
the two sympathins whose existence was first proposed by 
Cannon and Rosenbleuth in 1933. 
If this is true, Dibenamine, which has been shown to block 
the excitatory effects of epinephrine but not its inhibitory effects, 
might be expected to block but not reverse the vasopressor effect 
of nor-epinephrine. This has been shown to be the case (13). 
(b) In Man 
One of Hecht's experiments (7) tested the effects of Dibena-
mine on neosynephrin when both drugs were given intravenously 
to 22 patients. This sympathomimetic compound is one of the 
type which appears to possess a predominant peripheral action in 
most individuals and to have few of the excitatory effects on the 
heart of epinephrine. It is noted that the bradycardia caused by 
reflex vagal slowing secondary to the usual rise in blood pressure 
does not occur when Dibenamine has been administered previ-
ously. This is apparently due to the prevention of a vasopressor 
response to the amine. As with epineohrine, Dibenamine pre-
vents abnormal cardiac rhythms. here those of the type which 
result from "sinus default" or "vagus escape". 
The fact that Dibenamine's main action on sympathomimetic 
amines is a blocking of their excitatory powers, especially with 
regard to the cardiovascular svstem, lends weight to the concep-
tion of Gaddum and Kwiatkowski. 1938, that these drugs exert 
their sympathomimetic effect on the body by preventing the 
destruction by oxidation of epinephrin and sympathin. 
5. Action on Certain Non-adrenergic Substances Which Affect 
the Cardiovascular System 
Dibenamine has been found to have a very slight effect against 
histamine, the physiological ooposite of epinephrine. However, many 
of its congeners (9) synthesized recently aopear to possess much 
Jlreater potency in this resoect than the antihistamines now in current 
clinical use (13). Since these substances also possess adrenergic block-
ing powers, an interesting field of soeculation is opened up regarding 
the mechanism of action of this whole series which can allow this dual 
property of opposition to certain effects of both histamine and epine-
phrine. 
The effect of Dibenamine on the pressor response to angiotonin 
has been found to be negligible (13). Specificity of action as an 
adrenergic blocki~g agent appears to be one of the main character-
istics of Dibenamine. 
6. Action on Hypertension 
The experiments with Dibenamine referred to above were made 
mainly on normotensive animals and human subjects. Of great interest 
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are several other investigations on experimentally-produced hyper-
tension in dogs and on patients with various types of hypertension. 
(a) In Animals 
Nickerson (14) produced renal hypertension in rats by com-
pressing the kidneys according to the technique of GroHman. 
Dibenarnine was administered orally and resulted in a marked 
decline in the hypertenisve level of the blood pressure. This per-
sisted for several days after the last dose of the drug. Nickerson 
believed at the time that this experiment might afford a ray of 
hope for the use of Dibenamine in lowering chronic renal hyper-
tension in man. However, in a later article (13) , he admits that 
evidence for the value of Dibenamine (as for the value of other 
adrenergic blocking drugs) for this purpose is still inconclusive. 
(b) In Man 
Hecht (7) found that in cases of hypertension in human sub-
jects, Dibenarnine occasionally lowered the blood pressure 
toward normal levels, but that this reduction was never striking. 
He attributes this failure of Dibenamine to the relatively small 
doses which can be safely administered in man, 6-7 mgm.jkgm, 
as opposed to approximately 20 mgm.jkgm. in animals. · 
Console (2) who investigated the effects of both tetraethy-
lammonium and Dibenamine on 96 patients with peripheral vas-
cular disease and hypertension found that neither of these drugs 
consistently reduced the blood pressure for a period long enough 
to be of value in the treatment of hypertens~on , nor even to aid 
in the selection of patients for sympathectomy. 
Haimovici and Medinets ( 6) report results at variance with 
those of Hecht and Console. They found that Dibenamine was 
always able to lower blood pressure toward normal in patients 
with early or only moderately advanced essential hypertension. 
A single intravenous dose of Dibenamine caused a really signifi-
cant lowering of the blood pressure, and one whose duration was 
many hours. This reduction could be maintained if the drug was 
administered at properly timed intervals. In patients with malig-
nant hypertension no change resulted from the use of the drug. 
Spear and Griswold (21) reported a case of intermittent 
hypertension, due to the presence of a pheochromocytoma, where 
the hypertension was definitely reduced to normal limits with · 
every injection of Dibenarnine. The drug here aided in proving 
the diagnosis of the tumor in a way less dangerous than the older 
method of using histamine to provoke an attack (20) and more 
definitely than by the more recent method of nullifying an attack 
for a very brief period by the use of a benzodioxane compound 
( 5). Dibenamine, because of its prolonged effect in lowering the 
blood pressure, which remained within normal limits for 24 
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hours, and in allaying the symptoms, which did not recur for 72 
hours, was very helpful in building up the health of the patient 
prior to surgery. 
It would appear, therefore,. that Dibenamine lowers hyper-
tension in man: ( 1) by attacking the excessive sympathetic tone 
which, many investigators believe, plays the primary role in the 
genesis of at least essential hypertension; (2) by rendering 
ineffective any circulating sympathin or epinephrine, as shown 
most clearly when a pheochromocytoma is present. Thus both 
the sympatholytic and adrenolytic properties of Dibenamine ar-e 
concerned in its action on hypertension. How useful this action 
is clinically is still a matter not finally elucidated. 
7. A ction on Peripheral Blood Flow 
Hecht (7) found that visible peripheral vascular dilation was not 
observed in resting normal individuals after Dibenamine administra-
tion, but was seen in subjects with peripheral vascular disease, e.g. , 
hypertension, thromboangitis, Raynaud's syndrome, etc. A marked 
rise in skin temperature was noted in these cases. Apparently Diben-
amine is able to block the excessive sympathetic tone governing per-
ipheral vessels in these conditions and thus permit more vasodilation. 
Console's findings (2) were similar to those of Hecht. His investi-
gations proved that peripheral blood flow in subjects with acute vas-
cular occlusions could be effectively increased by the use Dibenamine, 
and that this action was much more prolonged than that of tetraethyl-
ammonium. In chronic vascul ar occlusions, temporary vasomotor par-
alysis can also be caused by D ibenamine, but its value here is more 
doubtful. However, Dibenamine may be useful in selecting certain of 
these patients for sympathectomy. 
8. A ction Opposing Lethal Adrenergic A ctivity 
(a) Administration of Fatal Doses of Epinephrine 
Raab and Humphreys (17) found that Dibenamine protects 
the heart of rats from normally fatal doses of epinephrine and 
permits their survival with normally fatal accumulations of epine-
phrine in the myocardium. Dibenamine is far more effective than 
Prisco! , or 933 F in this respect. 
Loew and Micetich (9) reported that Dibenamine protects 
mice against toxicity of epinephrine injected two hours later. 
However, they feel that the magnitude of the dose required and 
the slowness of onset of the protective action of the drug do not 
justify the designation of D ibenamine as the powerful adrenergic 
blocking agent Raab and H umphreys considered it to be. This is 
especially evident when Dibenamine is contrasted with other 
more active members of its own family, the beta chloroethyl-
amines. However, Dibenamine is admittedly superior to Priscol, 
Yohimbine and the Fourneau compounds. 
110 UNIVERSITY OF WESTERN ONTARIO MEDICAL }OURNAL 
(b) Excessive Sympathetic Activity Following Shock 
Ordinarily excessive compensatory vasoconstruction follows 
severe haemorrhage and this leads to the shock state. Wiggers 
et aL (22) found, in experimenting with dogs, that the adminis-
tration of a very small dose of Dibenamine (2-4 mgm.jkgm.) in 
the middle of the post-haemorrhagic hypotension period im-
proved the blood flow to such organs as the kidneys, liver, and 
intestines even under the prevailing low blood pressure. .Appar-
ently the abolition of severe vasoconstriction delays the onset of 
irreversible shock, for SO% of the Dibenamine-treated group 
survived as compared with 30% of the controls. 
Remington et al. (18} conducted somewhat similar experi-
ments with dogs. However Dibenamine was administered one 
hour before, rather than after, the haemorrhage was begun. In 
the treated dogs the survival rate was 90% after a haemorrhage 
of 30 c.c. among the controls only 7% survived. Pulse rate and 
blood flow per second were consistently greater in the treated 
group. 
These investigators also tested the effect of Dibenamine on 
the shock following muscular trauma. Of the group of dogs 
treated with Dibenamine before the administration of multiple 
blows with a mallet on each hind-leg, 89% survived; of the con-
trols 100% suffered fatal shock. Dibenamine's protective activity 
seems to be due to its prevention of the high degree of vaso-
constriction which follows muscular trauma, apparently brought 
about by afferent nervous discharge from the traumatized limbs. 
The largest part of this description of the pharmacodynamics of 
Dibenamine has been confined to the action of this chemical on the 
cardionvascular system. This has been deliberate since the action of auto-
nomic drugs can usually best be studied with reference to this system. 
Workers qave been able to perform clear-cut experiments and to record 
the changes in a system which is sensitive to small amounts of sympathin 
or epinephrine and also of their opponent, Dibenamine. 
However, there are a number of other interesting actions of Diben-
amine on the body which should also be mentioned. 
ll. A ctions on the Eye 
(a) In Animals 
In intact animals Dibenamine causes miosis, ptosis of the eye-
lid , and marked extension of the nictitating membrane. 
Dibenarnine prevents or reduces the mydriasis, widening of 
the palpebral fissure, and retraction of the nictitating membrane 
usually induced by administration of epinephrine or by cervical 
sympathetic nerve stimulation (14). 
(b) In Man 
Miosis appears early and persists for the duration of Jtction of 
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Dibenamine, and is the most sensitive indicator of the activity of 
the drug (7). 
The effect of Dibenamine on the ciliary body and accommo-
dation is not yet known; when the effect is discovered it may 
provide information as to the role of the sympathetic nerves in 
accommodation. 
Ill. Other Actions of Dibenamine 
(a) In Animals 
1. Dibenamine abolishes the pilomotor response to sympathetic 
nerve stimulation ( 14). 
2. It prevents the contraction of the spleen which is largely re-
sponsible for the erythremia and leukocytosis which normally 
occur during excitement (14). 
3. It blocks the response of denervated effector cells to epine-
phrine so that when Dimenamine is previously administered 
they fail to respond to 100 or more times the effective 
dose (13). 
(b) In Man 
1. The nasal mucosa becomes congested after Dibenamine in 
many of the human subjects tested (7). 
2. Spontaneous sweating in certain body areas is prevented by 
Dibenamine (7, 13). This is an interesting finding because, 
although the sweat glands are innervated by fibres from the 
sympathetic system, they are generally considered to function 
under the direction of the parasympathetic. However, some 
sympathomimetic amines cause sweating; epinephrine does . 
not do so presumably because of its local vasoconstricting 
action. Nickerson (13) reports a study by Haimovici of 
palmar sweating and its inhibition to a marked degree by 
Dibenamine. Moreover, the sweating caused by neo-
synephrine is completely blocked by Dibenamine. Jt seems 
likely, therefore, that adrenergic sweating in certain cutaneous 
areas of man is a normal body process; Dibenamine may help 
to elucidate the complex mechanisms of sweating. 
IV. Certain Responses Not Affected by Dibenamine 
1. The respiratory effects of epinephrine are not altered, i.e. the 
transient "epinephrine apnea" is not blocked by doses of Dibena; 
mine which readily reverse the blood pressure response; hyper-
ventilation, elicited by large doses of epinephrine, still occurs; the 
bronchial musculature is believed to relax as usual ( 13) . 
2. The metabolic effects of epinephrine are not altered by Diben-
amine. For instance, the rise in blood sugar is not prevented; in 
fact it occurs more quickly after Dibenamine for the epinephrine 
more readily enters the systemic circulation since it no longer 
limits its own absorption by local vasoconstriction ( 13) . 
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3. Smooth muscles which are relaxed by epinephrine or sympathetic 
stimulation are uninfluenced by previous administration of 
Dibenamine, e.g. the intestine and the non-pregnant cat uterus 
still relax after this drug when stimulated adrenergically. How-
ever, in contrast the rabbit uterus which is normally stimulated 
by epinephrine to contract, relaxes when Dibenamine is previ-
ously administered. This is further evidence that Dibenamine, 
which cannot block the inhibitory adrenergic functions, is fully 
able to block any excitatory ones (14). 
4. The functions of the gastrointestinal, genitourinary and somatic 
neuromuscular systems are nol apparently changed. Similarly 
body temperature and the blood picture are not altered. Not much 
is yet known of the action of Dibenamine on renal haemodynamics 
and renal function ( 13) . 
TOXICITY 
I. Side-Effects 
1. Oral Administration 
Rockwell (19) found that the only reactions to enteric-coated 
capsules were nausea and vomiting in 5 of 50 patients with the 
first dose. However, Hecht (7) and other investigators found that 
nausea, vomiting, and burning in the epigastric area were frequent . 
Moreover, pharmacological effects in doses which could be toler-
ated were found to be unpredictable ; accordingly oral administra-
tion has been abandoned by most workers in favor of the intra-
venous route. 
2. Pat·enteral Administt·ation 
This rou te produces some unpleasant reactions, such as pain 
along the injected arm, in a ma jority of patients, according to 
Hecht (7) . The only safe parenteral method is intravenous in-
fusion in hospitalized patients. Extravasation may result in pain 
and local tissue damage. Direct intravenous injection sometimes 
causes venous thrombosis. Too rapid infusion may result in 
nausea, vomiting, central excitation, tremors, etc. at least 60 min;-
utes should be taken for administration of the infusion. 
II. Acute and Chronic Toxicity 
1. Local Tissue Damage 
As pointed out above, Dibenamine is chemically related to the 
nitrogen mustards, and this in all probability accounts for the 
tissue necrosis which it can inflict unless very carefully adminis-
tered. 
2. Central Nervous System Excitation 
In both animals and man too rapid injection causes acute symp-
toms such as coordinated convulsiOns. The central effect is appar-
ently independent of the adrenergic blocking action for it appears 
earlier and disappears earlier than the latter action. Moreover, the 
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congener of Dibenamine, N ,N -bibenzyl animoethanol, possesse~ 
no adrenergic blocking power, but shows a similar convulsive 
action. An odd psychic feature of the central effect of Dibenamine 
was a disturbance of time sensations with some hallucinatory 
features and with repetitive perceptions of actual events so that an 
incident just occurring seemed to have been already experienced. 
This psychosis was noted in 15 of Hecht's 70 patients (7) and 
lasted for two to three hours. Consciousness usually was at its 
height. Psychiatrists may find Dibenamine useful for elucidating 
this phenomenon which occurs without known cause in certain of 
the mentally ill. 
3. Only Slight Cumulative Toxicity Has Been N_oted 
Nickerson reports (1 4) that growing rats subjected to daily 
subcutaneous injections of 3 times the adrenergic blocking dose 
for a period of 4 months showed no permanent ill effects and only 
a slight decline in the growth rate during the period of treatment. 
Hecht reports (7) that human subjects treated with the average 
tolerated dose, 4-6 mg..fkg., showed no striking alterations in 
blood counts, urinalyses, electrocardiograms, temperature, or body 
functions. Of great importance is the fact that Dibenamine does 
not possess the property so characteristic of the nitrogen mustards 
of producing a toxic effect on the bone marrow (13) . 
Ill. Therapeutic Ratio 
The relationship between the effective and the toxic doses of 
Dibenamine is on the order of 10 - 100. a therapeutic ratio which, 
although not high, compares favorably with that of other adren-
ergic blocking agents. Slow intravenous administration appears to 
give the greatest margin of safety in animals (14) . 
Dosa~r.e 
The manufacturers of the drug state that a "single dose for adults is 
5 to 7 mgm . per kg. body weight, with the average dose 6 mgm. per kg. 
Regardless of weight, the single total dose should not exceed 500 mgm. 
(contents of one 10 c.c. ampule) . The single dose may be repeated two 
or three times weekly." (Quoted from the circular which accompanies 
supplies of the ampules.) 
Dibenamine is also available in enteric-coated tablets of 130 mgm. 
for oral administration. 
Absorption, Onset and Duration of A ction 
No specific information on absorption by the oral or the various 
parenteral routes is apparently available in the literature at present, prob-
ably because the intravenous route has largely displaced other methods of 
administration by reason of its greater safety. 
The onset of action is rather slow, especially in comparison with that 
of some of its congeners (9). Loew reports that it failed to decrease the 
toxicity of epinephrine until the third hour but protected the mice until 
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18 hours after treatment. Nickerson "(14) states that the maximal block-
ing action is not observed until at least 30 minutes after administration of 
the drug but that the duration of effect from a single injection is from 36 
hours to 5 days. Haimovici ( 6) found that the depressor effect started at 
the end of the (slow) infusion and lasted 24- 72 hours. 
Although Dibenamine may be considered slow in onset as compared 
to other recently synthesized beta-chloroethylamines (known in the liter-
ature as SY compounds and still very much in the investigational stage as 
far as presen~ use is concerned), it i!i fairly rapid in its commencement of 
action compared to other clinically available adrenergic blocking agents. 
Its long duration of action is admitted by all investigators. 
Mechanism of Action . 
It is considered likely ( 6, 15) that the site of action is the neuro-
effector cells where Dimenamine blocks the sympathetic impulses or the 
action of sympathomimetic substances (sympathin E, epinephrine). 
The prolonged blocking effect of a single dose of a drug which is 
known to become inactivated within a few minutes at the pH of the body, 
suggests, Nickerson feels, that there is "prolonged inhibition, or actual 
destruction, of some structure or substance involved in the excitatory 
responses to epinephrine and its slow reactivation, repair or replacement 
so that complete recovery occurs without residua" {15). In later articles 
-(14, 16) Nickerson rules out, by a process of elimination, "any major 
effect of Dibenamine on (a) autonomic ganglia, (b) post-ganglionic 
neurones, or (c) on the release, alteration or destruction of epinephrinf' 
and sympathin", so that he feels Dibenamine's action must be exerted 
directly upon the effector cells (i.e. vascular smooth muscle). 
The action on the effector cells could then be exerted in three ways: 
"(i) by preventing the penetration of sympathomimetic agents to their 
site of action, (ii) by blocking or destroying some receptor substance or 
mechanism necessary for excitation by these agents, (iii) or by attacking 
the contractile mechanism itself." Nickerson's experiments (16) upon 
the nictitating membrane of the cat lead him to favor (ii) and he discusses 
at length the manner in which he believes Dibenarnine may act. 
Comments 
The above review of the literature on this interesting new drug 
shows that there is still a good deal of controversy as to the practical uses 
to which it may be put, e.g. there is no general agreement as to bow use-
ful it may be in treatment of certain conditions as hypertensive disease, 
peripheral vascul.ar disease, shock, ventricular arrhythmias in patients 
under anesthesia, etc. However, it seems apparent that it will be useful in 
the dia_gnosis and the treatment of some. at least. of these conditions, per-
haos to be displaced later by other members of its own family, once their 
oharmacology and therapeutic indices are also fully worked out. Diben-
amine does seem to have certain advantages in soecificitv of action, long 
duration and completeness of blockade, and wide margin of safety over 
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some of the drugs currently in use as adrenergic blocking agents, e.g. 
Yohimbine, Priscol, the Fourneau benzodioxone componds, tetraethyl-
ammomium, etc. 
Interesting new vistas of speculation and experimentation are opened 
up by the discovery of so active a drug, quite apart from its immediate 
practicality. The whole field of autonomic activity can be reviewed with 
fresh interest and Dibenamine can be used as a convenient tool in the 
attempt to elucidate more of the mysteries of the sympathetic and the 
parasympathetic systems. 
New possibilities of investigation may also arise from the central 
effects of Dibenamine, and psychiatry gain new knowledge. It is inter-
esting to note that one experimenter, Medinets (11), has already 
announced certain discoveries with regard to the catatonic state of schizo-
phrenic patients, in this case making use, however, of the adrenergic 
blocking action of the drug. 
The workers on Dibenamine, scattered in laboratories and clinics 
over most of the continent, have gradually built up a large store of infor-
mation on this drug in the last three years. Further coordinated studies on 
it and its congeners should soon prove tremendously worthwhile both for 
the field of Medicine and the field of Pharmacology itself. 
Summary 
Dibenamine, one of a new series of potent, specific and long-lasting 
adrenergic blocking agents, has been investigated by laboratory and clin-
ical workers since 1946. Chemically related to the nitrogen mustards, it 
must be carefully administered, preferably by the intravenous route, to 
avoid causing tissue necrosis similar to that caused by these related sub-
stances. Its systemic effect is to cause blockage of all excitatory adren-
ergic functions, thereby often throwing into relief concurrent but previ-
ously invisible inhibitory adrenergic functions which it is unable to block. 
A variety of experiments which have been performed on both laboratory 
animals and human subjects to demonstrate its pharmacodynamics are 
then described . These pertain chiefly to Dibenamine's action on the cardio-
vascular system for it is here that the most dramatic and potentially the 
most clinically useful results of its opposition to epinephrine andj or 
sympathetic nerve stimulation are apparent. It is notable that Dibenamine 
does not affect the chronotopic or positive inotopic effects of epinephrine 
on the heart; it opposes chiefly the peripheral vasoconstriction which 
epinephrine .induces. 
The acute toxic effects of Dibenamine are local tissue necrosis and 
central excitation, both of which can usually be avoided by a careful and 
slow intravenous administration of the drug. Chronic toxic effects are 
usually not noted as there is only slight cumulative toxicity. The thera-
peutic ratio, although not high, compares favorably with that of other 
adrenergic blocking agents. 
The possible mechanism and site of action of Dibenamine, the dura-
tion of effects and the dosage used are discussed. Possible clinical and 
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laboratory uses for the drug are suggested and a comparison of its effect-
iveness with that of other adrenergic blocking agents is made. 
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PORPHYRIA 
By J. E. MULLENS, '49 
P OR-PHYRIA is a name given to a group of conditions which are due to inborn errors in metabolism and characterized by the excretion of 
porphyrins in the urine. One must be careful to distinguish the term 
porphyrinuria (porphyrins in urine) from porphyria. Although porphy-
rins occur in the urine in porphyria, not all porphyrinuria is due to por-
phyria. Porphyria is a disease enttty, while porphyrinuria is merely a 
symptom. 
In the last few years a great deal of interest has arisen concerning the 
role of porphyrins in health and disease. As yet the subject is in a state of 
flux, and the center of much controversy. Therefore, this paper cannot be 
too dogmatic or authoritative, its main purpose being to stimulate interest 
in the porphyrins and their relation to clinical medicine. 
Before the clinical aspects of porphyria can be discussed it is essen-
tial that a very brief reference be made to the chemistry of the porphyrins. 
A few facts must be known in order to have some idea of etiology, and 
of the detection of porphyrins in the urine--a clinical necessity. 
Chemistry of Porphyrins 
Every porphyrin is composed of 4 pyrrol nuclei joined by methene 
bridges to form a ring. Each pyrrol nucleus is a five membered ring with 
4 carbons and a nitrogen and 5 replaceable hydrogens. When these are 
linked together to form the porphyrin nucleus there are 8 replaceable 
hydrogen atoms present. Individual porphyrins are determined by the 8 
side groups which each may possess. Hans Fischer synthesized 4 aetio-
porphyrins, which have 4 methyl and 4 ethyl radicals. Four differing 
arrangements are possible and thus these aetioporphyrins are named I, II, 
III, and IV. All other porphyrins are named according to which aetio-
porphyrin their configuration corresponds, regardless of the substituted 
radicals. 
All naturally occurring porphyrins belong to I or III. II and IV con-
figurations or types have never been found in nature. The porphyrins of 
the respiratory pigments, i.e. hemoglobins, cytochrome, catalase, as well as 
the free protoporphyrin of the erythrocytes all belong to type III. Copro-
porphyrin I occurs naturally in meconium, feces, and urine. T ype III, 
coproporphyrin, also occurs naturally in the urine. The prefix copro is 
used because it was first isolated from the feces. 
It is important to note here that it is quite unlikely that a type I 
porphyrin could be derived from a type III porphyrin (or vice verse) in 
nature because this could only happen by the breakdown and resynthesis 
of the whole molecule. Thus the coproporphyrin I in urine cannot be de-
rived from the respiratory pigments. This formation of 2 types of por-
phyrins in nature independent of each other is what Fischer called the 
"dualism of the porphyrins" . 
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Uroporphyrin is a porphyrin first isolated from the urine and later 
from the feces. It occurs only in pathological states and is evidence of a 
constitutional biochemical fault. · 
Physics of Porphyrins 
The name porphyrin comes from the Greek word porphuros, mean-
ing crimson or purple. Porphyrins ar~ reddish-brown to red, depending 
upon their solvent, and its pH. 
The absorption spectra are characteristic but a · very precise spectro-
meter is required . The old spectrometers were the cause of the artificial 
haemato-porphyrin being confused with natural · porphyrins, as their 
absorption spectra are quite similar. 
In the longer waves of ultra violet light there is intense red fluores-
cence. The emission spectra in ultra violet light is characteristic but does 
not separate the isomers. The identification of isomers depends upon 
(1) melting point of the crystalline methyl esters, (2) crystalline form, 
(3) fluorescence curves obtained from porphyrin solutions of varying pH. 
PORPHYRIA 
Clinically there are 3 types of porphyria. Gunther named these con-
genital, acute, and chronic. Recently the term "chronic" has fallen into 
disuse. Waldenstrom prefers the term "porphyria cutanea tarda" be sub-
stituted for the term chronic. He identifies it as a late form of congenital. 
Many do not mention chronic in their classification. 
It should be noted here that the term haemato-porphyria is archaic 
and incorrect despite its persistence in some good texts. 
I. Congenital Porphyria · 
This is inherited as a Mendelian recessive. It occurs usually in males 
and usually before the age of 15 years. It is much less common than acute 
porphyria. It runs a long and debilitating course, death finally being due 
to intercurrent disease or anemia. 
Red urine is the first sign of the disease and may precede the skin 
lesions by weeks or years. Tests show the porphyrins are uroporphyrin I 
and coproporphyrin I. Isolated instances of type III porphyrins in the 
urine have been reported. 
There is characteristically a hypersensitivity to light. This manifests 
itself in skin lesions of a bullous nature. The bullae are large, show no 
umbilication, and are distributed chiefly on the exposed portions of the 
body. It begins with itching or burning of the skin, photophobia and 
conjunctivitis. There may be oedema and hyperemia of the face. At the 
same time malaise, nausea and headache are common. When uncompli-
cated the lesions heal with little but definite scarring. Suppurative lesions 
occur in the presence of secondary infection, and when this is present, 
marked scarring, deformity, and disfigurement of the hands and face 
occurs. The scars become pigmented. This skin affection occurs typically 
in the spring and summer unless the patient is protected from sunlight 
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and is therefore called hydroa aestivale or vacciniforme. It must be noted, 
however, that all hydroa aestivale is not due to porphyria. 
Ocular damage may occur from scarring and deformity. Such lesions 
as conjunctivitis, chemosis, bullae on the cornea, leukoma, posterior 
synechia, and symblepharon occur. The lids may be narrowed, or ectro-
pion may result. 
The fingers and nails are often deformed. The nails may be lost, and 
in some cases may be red in colour. 
Erythrodontia, or red teeth, are an interesting feature of the disease. 
The colour, though, may range from distinct red or brown to normal. 
Endocrine disorders seem common, e.g. toxic goitre, hirsutism, etc. 
Borst and Konigsdorfer found morphological changes in the endocrine 
glands. 
Hepatomegaly andj or splenomegaly occur, more commonly spleno-
megaly. The splenomegaly may not be found in the young but usually 
appears as the patient grows older. 
Anemia is a significant feature of the disease. Normoblasts, megalo-
blasts, punctate basophilia, and polychromasia have been seen. Megalo-
blasts are rare in the blood, and though they occur in the bone marrow, 
the colour index usually diminishes as in any secondary anemia. 
The feces are not characteristic unless the porphyrin content is high, 
then they become black on oxidation. Both coproporphyrin and uro-
porphyrin are present. 
Congenital porphyria has no heredity connection with acute por-
phyria, although Nesbitt and Katkins have seen a family where one mem-
ber had acute porphyria and another had congenital porphyria. 
Differential. Diagnosis of Congenital Porphyria 
The skin lesions are not pathognomic. The deforming character may 
resemble lupus or leprosy. Scleroderma may be simulated. The lesions 
may be confused with epidermolysis bullosa because trauma also raises 
vesicles in some cases of porphyria. A urine examination should be suf-
ficient in most cases to differentiate, however, if the urine is negative for 
porphyrins it does not rule out congenital porphyria and the blood serum 
should be examined. 
The skin lesions and the teeth may show fluorescence in near-ultra-
violet rays if the porphyrin content is high enough. 
Splenomegaly may be present but the spleen is not as large as in the 
splenic anemias. This could confuse due to the anemia which is often 
present in porphyria. Because the splenomegaly only appears with time 
it is presumed to be secondary. 
The anemia present is often associated with signs of abnormal bone 
marrow activity, e.g. normoblasts, erythroblasts, megaloblasts, and eryth-
rophagocytosis. Petry, the original classical case of congenital porphyria, 
showed the picture of pernicious anemia late in the course of the disease, 
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and an indirect Van den Bergh reaction. Here again the examination of 
the urine will usually differentiate. 
II. Acute Porphyria 
This disease is inherited as a Mendelian dominant with a low inci-
dence of expression. Contrary to the name it is actually a chronic dis-
order. It is more common in women and in the third to fifth decades. 
There is usually a high mortality after a relatively short duration, due to 
respiratory paralysis. 
Some people distinguish a toxic and an idiopathic form. Gunther 
originally, and many authorities since, think that toxic substances only 
precipitate the symptoms of a condition already present. Toxic porphyria 
may be precipitated by lead poisoning, barbiturates, sulfonal, trional and 
other substances. There is no justification in recognizing a toxic form as 
the symtoms are identical and only the history can differentiate. 
SYMPTOMATOLOGY 
1. Abdominal symptoms: Severe abdominal pain of a colicy type is com-
monly one of the first symptoms. It is often in the lower abdomen but 
may become generalized. Radiation to the thighs is not uncommon. 
A case has recently been reported in which there was urgency of mic-
turation during the acute attacks. The abdomen is typically soft. The 
attacks may be often seen post-partum, or associated with the menses. 
Nausea and vomiting are usually present and frequently severe. 
Constipation is nearly always present and may be quite severe. Diar-
rhoea occurs but rarely. 
2. Jaundice occurs sometimes and is usually mild . This is to be distin-
guished from the comm nl y occurring diffuse skin pigmentation. This 
pigmentation occurs chiefly on the face and abdomen and may be in 
freckle or chloasma-like spots, especially on the face. This pigmenta-
tion does not involve the mucosal surfaces. There is often darkening 
of the hair. The acute attack may be preceded by years by the pigmen-
tation, which may become worse during attacks. Incidentally the cause 
of the pigmentation is unknown. 
3. Hypertension and tachycardia occur often and especially during 
attacks. 
4. Oliguria is commonly present. 
5. Neurological and Mental Symptoms: Porphyria may play a 
minor role in the production of the neurological symptoms as por-
phyrinuria may occur after the symptoms have been established. Con-
trary to the prevalent idea, Wildenstrom states that an ascending 
paralysis is not the commonest neurological symptom, although this 
Landry form of paralysis is common. 
There are often irregularly distributed paresis. There may be 
only a single group, or nearly all striated muscle may be affected. 
Symptoms similar to those of polyneuritis may be marked. Con-
vulsions, delirium and coma are sometimes seen. 
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Hysteria is a common diagnosis because of the curious paresis and 
pains all over the body. There may be initially a feebleness which can 
be overcome by strong volition. This is a hysterical picture. The pass-
ing attack of blindness which can occur may be diagnosed hysterical 
amaurosis. Paralysis is usually preceded by nervousness, irritability, 
pain in the lower extremity, or discomfort and aching. Such sensory 
disturbances as hypaesthesia, or paraesthesia may be present. These 
symptoms may precede the abdominal pain by a few days to a few 
weeks. 
Paresis and loss of reflexes in the legs and soon involving the 
arms is often seen. Complete flaccid paralysis may ensue. During this 
2 - 3 week interval the patient may be irrational. Visual and auditory 
hallucinations are encountered, and delirium may alternate with 
apathy. there may be other psychopathic phenomena, e.g. maniacal 
or depressive states, or epileptiform seizures. A true Korsakoff's 
psychosis may develop, viz.: acute toxic psychosis with polyneuritis. 
Waldenstrom points out that many porphyries are in asylums. In 
studying the family history of porphyries it seemed to him that there 
were more than an average number of manic-depressives and schizo-
phrenics in the family. Watson suggests that it would be a good idea 
for someone to survey the clinical material in our mental hospitals as 
Waldenstrom did in Sweden, and doubtless many porphyries would 
be discovered. 
In the late stages of the disease bulbar paralysis and therefore 
dysphagia and dysarthria are commonly seen. Amaurosis and ocular 
palsies are also seen. Finally incontinence, coma and death ensue. 
Mild cases have recovered and some others have had remissions 
and relapses. 
6. The urine is usually a burgundy red or amber, becoming red on expos-
ure to light. The appearance of the red colour is hastened by oxidizing 
agents. Originally it was said that the urine contained uroporphyrin 
III and I and in some cases coproporphyrin II:t. However, recent work 
has shown that what was formerly considered uroporphyrin III is 
actually uroporphyrin I with an unidentified type III porphyrin. 
The chromogen porphobilinogen is present in the urine and is 
specific for acute porphyria. It is stable when in alkaline urine but 
when acid it becomes porphobilin and what was formerly known as 
uroporphyrin III. Porphobilin was formerly known as urofuscin, and 
is simply a pigment. Some porphyrins in both acute and chronic por-
phyria are commonly excreted as complex metallic compounds-zinc 
especially. 
7. Photo sensitivity has been reported but is extremely rare. 
8 . The following also have been noted : 
(a) Sudden development of Grave's disease 
(b) Ob'esity of the Frohlich's type 
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(c) Changes in the pituitary and adrenals 
(d) Virgin secreting colostrum _ 
(e) A man with swelling of the breasts during an attack 
(f) A lesion of coeliac ganglion. 
9. Remissions and exacerbations occur especially in the abdominal type. 
The neurological type has a mortality of 50-75 per cent. Mixtures of 
symptoms do occur commonly in any combination. 
Differential Diagnosis of Acute Porphyria 
1. Examination of Urine: 
The urine may be red only on 'exposure to light, especially sun. Por-
phobilin may be responsible for most of the colour. It has been con- · 
fused with urobilin. Watson and Schwartz have devised a simple test 
for the detection of urinary porphobilinogen. Equal parts of Ehrlich's 
solution, urine, and a saturated solution of sodium acetate are mixed. 
A few c.c.'s of chloroform are added. Porphobilinogen remains in 
aqueous solution and urobilinogen is extracted by the chloroform. 
More chemical procedures for the detection of porphyrin isomers 
will be omitted here for brevity. 
2. Abdominal Condition: 
Laparotomies have been done for obstruction, appendicitis and gall 
bladder disease. 
There is in this condition (porphyria) a leucocytosis of 15-20,000 
and a temperature of 100-102". 
Gunther's triad of vomiting, colic, and constipation is almost in-
variably present. 
The x-ray shows bowel spasm especially in the ileum. The stom-
ach and colon may be dilated. 
When an ascending peripheral neuritis is present the diagnosis is 
complete, but this is not always present. 
3. Neurological : 
Some of the entities ~ith which it has been confused are poliomyeliitis, 
progressive muscular atrophy, periarteritis nodosa, cerebral tumour, 
hysteria and various psychoses. Should a suspicion of porphyria be 
present, the simple test outlined above will decide the ·issue in most 
cases. 
111. Chronic Porphyria 
No genetics are known about this condition." The symptoms of both 
congenital and acute may be present in a milder form. Waldenstrom be-
lieves it is a form of congenital porphyria. 
The skin is somewhat sensitive to light. Abdominal or neurological 
symptoms may be present singly or in combination. Severe neurological 
symptoms are not present. 
Coproporphyrin I and III and. uroporphyrin I and III are excreted in 
the urine. Gray, Rimington and Thomson mention only uroporphyrin III. 
PoRPHYRIA 123 
Chronic porphyria develops later in life, and a sclerodermic tendency 
is noticeable. 
Before studying the etiology the pathology should be summarized: 
Pathology 
1. Congenital Porphyria: 
The skin lesions show necrosis of the epidermis due to capillary dam-
age in the corium. It is not primarily epithelial, therefore, but vas-
cular. 
The teeth vary from red to normal and contain uroporphyrin I. 
Uroporphyrin I and coproporphyrin I are found in the cells of the 
bone marrow. U roporphy.rin I is also deposited in the bones. There 
is hemosiderosis of the bone marrow, spleen, and liver. 
2. Acute Porphyria: 
Hepatic damage has been noted frequently. Recently Gray, Rimington 
and Thomson noted significant changes in the hippuric acid test when 
jaundice was present. In addition to disturbed liver function, disturbed 
calcium and cholesterol metabolism have been observed. 
Abrahams, Gavey and Mclagen reported a case in 1947 in which 
low serum chlorides and serum sodium were present. To their knowl-
edge these determinations have not been done in other cases. They 
noted that during exacerbations the symptoms were much like adrenal 
insufficiency though at autopsy the adrenals were anatomically nor-
mal , and therapeutically adrenal cortical extract and sodium chloride 
did not avert death. 
Prunty observed liver damage, hemosiderosis of liver and por-
phyrin in the liver cells . The kidney and the costal cartilages also 
contained porphyrins. Waldenstrom has found arteriolar medial 
sclerosis and necrosis. 
ETIOLOGY 
A . General 
Porphyria has a universal distribution, and is not peculiar to humans. 
Typical congenital porphyria has been found in pigs and cattle. It is 
interesting, however, that nearly all of Sweden's porphyries reside in one 
province. 
It has been said before that some porphyrins are in the urine norm-
ally. The source of coproporphyrin in urine and feces is not likely to be 
meat because it may be found in vegetarians. There is a possibility that 
excretion is related to hemotopoietic tissue because excretion rises when 
hemotopoiesis is increased. Watson says that both uroporphyrin I and 
coproporphyrin I are formed in the erythrogenic cells of the bone mar-
row. Coproporphyrin I excretion increases in pernicious anemia and in 
hemolytic jaundice. 
All of the porphyrins sensitize to light in varying degree but porphyr-
inogens and metallic salts of porphyrins do not. Uroporphyrin has the 
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most photodynamic action of all. They also produce smooth muscle spasm 
which is intractable to atropine. Intestinal colic, hypertension, oliguria, 
retinal vessel spasm and peripheral neuritis are regarded by some as por-
phyrinopathic whether it be idiopathic or toxic porphyria, e.g. lead 
poisoning. Porphyrins are excreted in large amounts in congenital por-
phyria, and less so in acute porphyria. This has been given as a reason 
for photosensitivity in congenital porpliyria. But this would mean that 
there is something wrong with the porphyrinopathic theory of bowel 
dysfunction because there is none in congenital porphyria. Turner says 
that the difference lies in the fact that the porphyrins are metal complexes 
in acute porphyria and not in congenital porphyria. Yet Watson has 
demonstrated free porphyrin in the blood serum without photosensitivity. 
Porphobilin also has been under suspicion as the cause of the 
pathology. 
Berg believes that porphyrins may produce a block at neuromuscular 
transmissions and inhibit acetylcholine at the synapses. It may interfere 
with the hydrolysis of acetylcholine in its relation to choline esterase or it 
may interfere with the synthesis and release of acetylcholine. It is inter-
esting to note that uroporphyrin occurs normally in foetal bones. 
B. Porphyrins in Drug Ingestion 
1. Lead Poisoning: 
Coproporphyrin III and a little coproporphyrin I are excreted in 
the urine. Increased light sensitivity has been reported. Calcium 
chloride administration clears the porphyrinuria and fluorescence 
from bones. The urinary coproporphyrin is rarely large enough to 
give red urine. Uroporphyrin III has not been observed. Yet the 
symptoms are practically the same as those of acute idiopathic 
porphyria. Even in ordinary lead poisoning the toxic manifesta-
tions have been attributed to porphyrinopathic sequelae. The 
lesser degree of symptoms . corresponds to a lesser degree of 
excreted porphyrins. Thus the calcium given therapeutically may 
remove circulating porphyrins as insoluble calcium compounds 
and deposit them in bone. 
2. Sulfonal and Trional Ingestion: 
Porphyrinuria here occurs almost entirely in women. Uroporphyrin 
I and III are reported as having been excreted. 
3. Salvarsan Injections: 
An increase in urinary coproporphyrin III occurs in some patients 
receiving injections, and in salvarsan dermatitis, but not always. 
4. Phosphorus: 
Causes an increase in urinary coproporphyrin . 
5. Selenium and Mercury: 
May cause increased excretion of coproporphyrin and also uro-
porphyrin. 
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6. Alcohol: 
Increase in urinary coproporphyrin III. 
7. Barbiturates: 
Controversial. 
C.. Seconda-ry or Symptomatic Cop-roporphyrinuria 
1. Jaundice and Liver Diseases: 
(a) Hepatic cirrhosis: 
The fatty cirrhosis following chronic alcoholism causes an 
increase in coproporphyrin III excretion, while non-fatty, 
idiopathic or post infective cirrhosis causes an increased excre-
tion of coproporphyrin I. The reason for this is not clear. But 
it is known that acute alcoholism temporarily increases copro-
porphyrin I excretion. 
(b) In Infectious Hepatitis coproporphyrin I is excreted in 
increased amounts. 
2. Poliomyelitis: 
There is excretion of urinary coproporphyrin III. Incidentally 
coproporphyrin III is present in the white matter of the central 
nervous system. This may or may not be significant. 
3. Anemia: 
Aplastic and hyporegenerative types increase the excretion of 
coproporphyrin I and III. 
4. Hodgkins' Disease and Leukemia also increase coproporphyrin 
excretion. 
5. A class of patients who appear to have functional bowel complaints 
have increased coproporphyrin excretion. Watson poses the ques-
tion, are the porphyrins responsible or are they indicative of a 
primary autonomic nervous system disturbance? 
Where do porphyrins come from? It has been hypothe:;ized that uro-
porphyrin III may arise from disturbed synthesis of respiratory pigments 
or abnormal destruction of hemoglobin. 
Dobriner and Rimington separately have hypothesized that the for-
mation of porphyrins is under enzymatic control. If a porphyrin ring is 
split transversely two dipyrromethane rings are formed. Designate these 
X and Y and assume they can occur separately in the body. Then 
X + Y = type III porphyrin 
X + X = type I porphyrin 
Y + Y - does not occur 
These reactions are under enzymatic control and normally III and I 
types are produced in a constant ratio. Porphyria could be a disturbance 
of this enzymatic control. 
In summary, one sees porphyrinuria in many clinical syndromes. In 
considering the etiology of po_rphyria it is interesting to note all the fore-
going data that it might shed some light on the cause. As yet, the details 
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of etiology arc obscure but it does appear as though porphyria has some 
tie-up with the symptomatic porphyrinurias. 
SUMMARY 
Treatment of Porphyria 
1. A void sul phonal, trional, lead, selenium, barbiturates, sulfonamides, 
arsenicals, alcohol and phosphorous. 
2. Abrahams, Gavey and McLagan suggest kaolin be given to absorb 
porphyrins in the bowel, but Watson maintains porphyrins in the 
bowel have no relation to urinary porphyrin excretion. 
3. Neostigmine and mecholyl have been used in acute porphyria with 
dubious results. Berg thinks they may actually be dangerous. 
4. Liver injections have been used in chronic and acute types with con-
troversial results. Theoretically the liver destroys porphyrins. 
5. Demerol and atropine are useless in acute porphyria. 
6. Alkalinizing the urine to decrease porphyrin excretion is useless. 
(Jorgensen and With) . 
7. Calcium chloride may or may not be of value. 
8. Protect congenital porphyries from trauma and sunlight. 
Discussion 
It is apparent that the investigations into a rare condition, porphyria, 
have opened up a vast new field for study in medicine, namely the role of 
porphyrins in health and disease. For example, what is their relation to 
liver disease, virus diseases such as poliomyelitis and infectious hepatitis, 
heavy metal poisoning, aplastic anemias, polyneuritis and mental disease? 
It has been the object of th is paper to stimulate interest in porphyria so it 
may be recognized , and in the relation of porphyrin metabolism to other 
aspects of clinical medicine. 
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~bstracts 
NEW POSSIBIUTIES IN PRIVATE 
PSYCIDATRIC PRACTICE 
c. P. 0BERNDORF 
Am. f . Psy~hiaJ. 105:589-593, Feb. '49 
After a brief account of the history of 
psychiatry and an evaluation of psychiatric 
methods, this article proceeds to consider 
certa.in problems and deficiencies in the prac-
tice of psychiatry. The psychiatrist, himself, 
is considered first. The isolating nature of 
the work of a private psychiatrist tends to 
limit his range and vision. To overcome this, 
the author suggests a part-time position in a 
sanitarium or other institution. 
Next, the matter of cost of treatment is 
considered. At prese.nt, 90% of the popul a-
tion cannot afford private psychiatric treat-
ment. A plan whereby private psychiatrists 
join in a "group practice" is advocated and 
the advantages of such a plan are enumer-
ated. Under such a system patients in low 
income groups would be treated at reduced 
fees and this would be possible '' through the 
circumstance that a younger man, whose 
practice in the early years is always uncer-
tain, would be assured of a definite income 
for a given number of hours' work a week." 
" Half-way houses" for the intensive treat-
ment of mild psychiatric cases are proposed 
as another facility in the private care of the 
mentally ill. 
The old family doctor who knew the emo-
tional setting of his patient is becoming ex-
tinct. A new and widening function of the 
psychiatrist is that of general family medical 
counsellor. This role is often attained only 
after the psychiatrist has treated some mem-
ber of the family. The family psychiatrist is 
consulted to evaluate proposals of other 
medical specialists for treatment-especially 
in cases where emotional factors are involv-
ed. Advice is also frequently sought by the 
family in regards to choice of vocation and 
other personal matters. 
The author believes that socialized or state 
medicine may eliminate the private psychia-
trist . But if present trends remain the same 
in this country (U.S.A.), private psychiatric 
practice will prosper providing it offers bet-
ter ervice at Jess expense. 
-EWAllT SCHENCK, ·~0 
GRAVES' DISEASE: TREATMENT 
WITH RADIOIODINE (I m ) 
MAYO H. SOLEY, EAlu. R. MILLER AND 
NADINE FOREMAN 
f . Clin. Endo~rinol. 9 :29-35, f an. '49 
One of the most promising of the medical 
implications in the study of radioactivity is 
the application of radioactive iodine in treat-
ing Graves' disease. In effect, the intention 
is to perform a sub-total medical thyroidec-
tomy. The authors report on the use of 
radioiodine (I 131) in Graves' disease. 
Animal studies on rabbits and dogs showed 
an early decrease in the size of the thyroid-
the ar teries showed medial and intimal 
fibrosis, thickening and perivascular fibrosis. 
Of the acini, only a few remained, these at 
the poles. The amount of Joss depended upon 
the uptake of }1 31 by the thyroid. ln some 
instances, renal and tracheal damage occurred, 
with no changes in other organs. 
To date, 68 true cases of Graves' disease 
have been studied, the majority of these with 
some thyroid enlargement. Dosages started 
with 2~0 microcuries of radioactivity, later 
were increased to 1000 and 4000 units, with 
a total dose up to 10,411 units. 
The uptake of 1131 was measured, using 
estimated weights of thyroid as judged by 
palpation and compared with actual weight 
of thyroid tissue removed in subtotal thyroid-
. ectomies. It was estimated that with no pre-
vious treatment, an average of 61% of 1131 
was taken up, whereas with those patients 
treated with Lugol's iodine or one of the 
thiouracils, an average of 48% was taken up. 
127 
- -----------~----------------
128 UNIVERSITY OF WESTERN ONTARIO MEDICAL jOURNAL 
The importance of the estimation was em· 
phasized, though it was admitted that the 
margin of error was high, and that the con· 
centration of Jl31 per gram of thyroid tissue 
was not directly related to the response. 
Response is defined as satisfactory if in 4 
months the signs and symptoms of thyrotox-
icosis have disappeared, the thyroid has re-
turned to normal size, and the ba al metab-
olic rate, level of serum protein-bound 
iodine, and other laboratory fin.dings are 
normal. Of the total, 42 patients were con· 
sidered to have had good response, 4 showed 
a delayed response (these were more evere 
cases), 2 were given subtotal thyroidectomies 
(one for possible neoplasm, the other be-
cause of poor cooperation) , 3 were consid-
ered ' 'slow responses," ~ were unavailable 
for evaluation, one became pregnant and the 
remainder have not yet been evaluated . 
The only complication mentioned was the 
development of myxoedema in 2 female 
patients. This occurred after a few weeks of 
therapy, with symptoms similar to those seen 
i.n the relapse of myxoedematous patients 
upon stopping thyroid therapy. It is stated 
that there may be some recovery in these 
patients, though follow-up i not yet com· 
plete. 
The authors mmment that time will per· 
mit resolution of the problems of election 
of patients, dosage, and administration of 
dosage. They conclude that radioactive iodine 
(JIH) in adequate dosage will cau e a sub-
total destruction of hyperfunctioning thyroid 
glands in patients with Grave · di ~e~se, pro-
ducing thereby satisfactory rem•s 1ons of 
signs and symptoms of the di ease. " Further 
studies ultimately will disclose its place in 
the therapy of Graves· disease:· 
-D. B. MELTZ~R, · ~o 
·EVALUATION OF THE VARIOUS 
CUNICAL SIGNS OF THROMBO-
PHLEBITIS AND EXPERIENCES 
IN THERAPY WITH ANTI-
COAGULANTS 
DAVJ1T A. FELDER, .M.D. 
SMr,., G,.•c. & Obsl. 88:337-3j0, 1949 
Dr. Felder presents a very comprehensive 
paper on the subject, in which he presents 
92 cases, representing 10::1 extremities with 
deep thrombophlebitis of the lower extremi-
ties. 
Diagnostic signs and symptoms used were 
swelling, vessel tenderness, pain, increased 
temperature of limb, dilated superficial veins, 
cyanosis, pulmonary embolism and change m 
temperature and pulse. 
The treatment used was : 
1. Heparin and dicoumarol in 84 cases 
(a) Heparin used for 1-2 days for 
most patients. ~0 mg. intravenously 
every 3 hours with clotting times ( 1 Yz 
hours after each dose) kept at 2 to 3 
times the patient"s normal dotting time. 
In some, the night therapy was given 
in one dose of 100 mg. at midnight. 
'Heparin in Pitkin's menstruum was 
used in 7 cases (300 mg. in 1 dose/day 
with a vasoconstrictor given subcutan-
eously) . Reports on coronamid pro-
longing heparin 's action are encourag-
ing. 
(b) Dicoumarol was given: 300 mg. 
the first day, 200 mg. the second day 
in 2 doses, and 100 mg. the third day 
in 2 doses. Prothrombin time was kept 
1.~ higher than the control normal for 
the patient. In bleeding complications, 
72 mg. Vit. K was given intravenously. 
The average treatment was for 14 
day, but was extended to 21 days in 
cases of pulmonary embolism. 
2. Bed rest-average 10 . ~ days. 
3. Com~on femoral ligation was per-
formed in 8 patients. 
In this series the incidence of secondary 
pulmonary embolism was 2 .17% and none 
of these was fatal. The complications of 
anticoagulant therapy are presented and dis-
cussed and do not appea.r to contra-indicate 
its use in most cases. 
The therapy ou dined appears to be ade-
quate for rno t ca es, but as Dr. Felder 
tates 'The answer to the question of 
thrombophlebitis does not lie in perfecting 
the anticoagulants and their administration, 
but rather in the fundamental cause of 
abnormal blood clotting." 
-EuNICE E. 0ESTilEJCHJ!R, M£os '49 
MANAGEMENT OF CHRONIC 
PEPTIC ULCER 
La•cel, 2j6:3j3, 1949 
The article deals with the management of 
chronic peptic ulcer. Early treatment and 
diagnosis are very essential, and many can 
only hope for reasonably normal lives with 
minor relapses. It is pointed out thatduring 
a.cute relapses, bed rest is definitely required 
but not to the point of boredom for the 
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patient. The change from an active life should 
be gradual until the patient comes to accept 
his disability. 
The drastic restriction on foods is felt to 
be open to question, and within reason the 
patient should eat what agrees with him. A 
little food, often, with proper timing and 
regularity is considered of prime importance. 
There is no di rect evidence that smoking is 
harmfuL Schnedorf and Ivy have found that 
gastric acidity is not increased ; if any effect 
at all, it retards evacuation and depresses 
gastric acidity. 
The barbiturates are felt to ~ the only 
drugs of value in all stages of peptic ulcer. 
Belladonna in the form of !-hyoscyamine is 
useful in the acute stage, because it allays 
spasm and reduces painful gastric contrac-
tions, but it is of no use beyond this stage. 
The danger of haematemesis from insoluble 
aspirin is noted. 
'"The successful management of a peptic 
ulcer , then, requires on the patient's part an 
avoidance of excess, a minimum of fuss, and 
an acceptance of the inevitable. It asks of 
the physician a humble recognition of the 
limitations of therapy and a sparing .md 
humane use of his veto." 
- DoNALD M . GooD, ·::;o 
THE PROBLEM DRINKER 
JOSEPH HIRSH 
D11el, Sloan and Pearu, New York, 1949, 
211 pp., IIIIIJI. u 
"Alcohol is a fact. We cannot hide it, we 
cannot avoid it. We have always had it. 
And as long as there is plant life on the face 
of the earth we cannot prohibit its existence. 
Alcoholic excesses and problem drinking are 
another matter. Their solution lies not in 
moralization, but in medical research, in 
treatment, in prevention, in honest education 
about how people function, and how alcohol 
functions-what it can do and does do to 
and for human beings." 
This paragraph well expresses the theme 
of this interesting, matter-of-fact book on 
the age-old problem of alcoholism. 
That excess drinking is an enormous prob-
lem is clearly demonstrated by the many re-
cent statistics. The author points out, for 
example., that out of sixty million consumers 
of a.lcohol in the United States, there are 
over three and one-half million excessive 
drinkers, seven and one-half thousand of 
whom are true alcoholics. These excessive 
drinkers, through wage loss, accidents and 
expenditures of p rivate and public welfare 
agencies, cost the United States over one 
billion dollars every year. 
In his attack upon this problem, the author 
believes that many of our present laws are 
inadequate. Imprisonment and neglect, he 
points out, are not substitutes for treatment. 
The author offers many suggestions as to 
what may be done about the welfare of the 
alcoholic and about his rehabilitation. 
Included in the book are excelle.nt chapters 
on the history of alcohol ; the pharmacology 
of alcohol ; the relation of alcohol to crime, 
to accidents, to divorce and to venereal dis-
ease. One chapter is devoted to the organ-
ization and principles of Alcoholics Anony-
mous. 
This book can be highly recommended as 
a useful and desirable book for any phy-
sician's library. 
- KEN RITCHIE, '50 
SOCIAL MEDIONE- ITS 
DERIVATIONS AND OBJECTIVES 
THE N EW YORK ACADEMY OF MEDICINE 
INSTITUTE OF SOCIAL MEDICINE, 1947. 
EDITED BY IAGO GALDSTON, M .D . 
The Commonwettlth F11nd-New Y ork 1949, 
294 pp. 
This extremely interesting book is com-
posed of an edited collection of papers given 
before the In~titute on Social Medicine 
formed in connection with the Centennial 
Celebration of the New York Academy of 
Medicine in the spring of 1947. The papers 
are printed in an orderly sequence and were 
given by many eminent authori ties not only 
in the fi eld of medicine, but also in the 
fields of history, philosophy, psychology, 
p~ychiatry, nutrition, economics, hygiene and 
public health, sociology and anthropology. 
Medicine as it is practised to-day still 
tends to diagnose and treat an illness in an 
individual , neglecting many of the factors 
which may contribute to and help sustain 
the illness, such as economic and social con-
ditions and many others. Although a great 
mass of facts is already known about the 
various aspects of environment which affect 
man's well-being and happiness, these facts 
are grouped into the separate fields named 
above. It was the purpose of this symposium 
to collect the opinions of various leaders in 
many fields of study regarding the useful 
knowledge which their respective fields are 
able to contribute towards a common pool of 
knowledge about the health of mao, both as 
an individual and as a society. 
This having been done, it was also their 
purpose to investigate means of integrating 
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the isolated fields into one study - social 
medicine - which would embrace the study 
of all contributions to the health of man. 
This is a positive study-to keep man happy 
and healthy as well as to treat him when he 
l,ccomes ill ; it embraces not only the ills of 
the individual patient, but also those of soci-
ety, which are many, as evidenced by the 
frequency of wars, the wretched physical and 
social condition of so many of its members, 
and so on. The book continually stresses the 
role that the medical practitioner should 
play in social medicine. It is to be noted 
that this is not a book about socialized medi-
cine as seen in Great Britain to-day ; it is 
about social medicine and the distinction be-
tween the two is adequately described. 
Anyone connected with the field of medi-
cine will find much of great value in this 
relatively short book. 
-DoUG. RICHARDsdN, '50 
HALLMARKS OF MANKIND 
FRBDBRIC WOOD }ONES 
Bailliere, Tywtia/1 anti Cox, London, 86 pp. 
The orthodox idea conce.rning the devel-
opment of man is that he is the highest de-
veloped member of the order Primates. That 
is to say that the order Primates is made up 
of a number of closely related animals that 
represent an evolutionary sequence from 
" lowest'" to '"highest," the lowest being rep-
resented by the Lemurs and the highest by 
Man. 
show that this concept of man's development 
may be entirely wrong. 
As a result of his studies in comparative 
anatomy Jones has come to the following 
.:onclusions: at an extremely early period, 
there existed a type of animal, perhaps un-
recognizable as a monkey, which was des-
tined to evolve into the Chimpanzee and 
Gorilla (African monkeys), the Orangs and 
Gibbons (Asiatic monkeys), and also Man. 
Through various natural forces a line of 
beasts, the Catarrini, developed. At a very 
early period a branch was produced from 
this main trunk which developed into Man. 
Some time later, after considerable special-
ization and polishing of the main trunk, a 
second branch was produced which became 
the Gibbon and Gorilla. After still more 
polishing and development the Chimpanzee 
and Gorilla were produced. 
It will be seen that if this be true, Man is 
actually, in str:~cture, a far more primitive 
beast than either Chimpanzee and Gorilla 
or Gibbon and Orang. The Gorilla, accord-
ing to Jones, is the apex of anthropoid de-
velopment rather than man. The less an ape 
has changed from its original form so much 
more human he appears. 
Although the evidence for these ideas are 
not as yet completely convincing, they are 
stimulating and add further weight to the 
adage of Bacon, " that which the mind grasps 
upon with especial readiness is to be re-
garded wtth suspicion." 
An interesting book for those interested in 
wandering along the byways of medical 
In this interesting little book, Wood Jones science. 
presents considerable anatomical evide.nce to 
-R. PRINCE, '50 
THE NATIONAL COMMITTEE FOR CHILE 
is now receiving gifts for the library of the Medical School of the Uni-
versity of Chile at its new collection center in the Library of Congress, 
Washington. The newer materials in the library, including periodicals, 
books and reference materials, were totally destroyed in the recent fire. 
Medical periodicals of the last ten years and recent medical books are 
urgently needed. Your contribution will be appreciated. 
National Committee for Ollie, 
Room 318, Library of Congress; Washington, D.C. 
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This is the first issue published by the 1949-50 staff of the Medical 
Journal. As is apparent, many changes have been made in the journal. 
These changes have been dictated by economic pressures which threaten 
the very existence of the journal. However, in spite of the limitations 
thus forced upon us we are striving to maintain a journal of high calibre 
which will bring articles of general interest to all our readers. 
The editors wish to welcome the reorganized Osler Society to the 
Medical School scene. This society meets regularly to present papers on 
medical history. W e feel that this is a very worthwhile study for medical 
students and graduates alike and we hope in the future to publish many 
of the papers presented at these meetings. In this connection we note 
with pleasure the appointment to the editorial board of the "Journal of 
the History of Medicine and Allied Sciences" of Dr. Lloyd G. Stevenson. 
Dr. Stevenson, a Western alumnus, is the author of "The Life of Sir 
Frederick Banting." We will await with pleasure the appearance in our 
journal of some of his articles on his return to Western. 
Finally, we welcome at all times any suggestions from any of our 
readers which will improve the Medical Journal. 
